data_2ogp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ogp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.207 0 CA-C-O 120.698 0.054 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 86' ' ' SER . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.696 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.696 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.428 ' CD2' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.536 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 51' ' ' ILE . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.536 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.4 pp0? -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 108' ' ' PHE . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.447 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 25' ' ' ILE . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 38' ' ' ILE . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 69' ' ' LYS . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.437 ' CG ' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.407 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.423 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.424 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 107' ' ' VAL . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.401 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.401 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.402 HD12 HG21 ' A' ' 56' ' ' ILE . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.431 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 76' ' ' GLU . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 86' ' ' SER . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 87' ' ' GLN . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.435 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 51' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HA ' HG13 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.43 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.417 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.494 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' CE ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.481 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.46 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 36' ' ' PHE . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CE1' HD13 ' A' ' 34' ' ' LEU . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 51' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 56' ' ' ILE . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 52' ' ' TYR . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.419 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD21 ' CG1' ' A' ' 90' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' CG1' HD21 ' A' ' 82' ' ' LEU . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.162 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' HG12 ' A' ' 90' ' ' VAL . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 ' CA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' CA ' HG23 ' A' ' 39' ' ' THR . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 108' ' ' PHE . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 75' ' ' ILE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 82' ' ' LEU . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.448 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.406 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.448 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.43 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 HG21 ' CA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CA ' HG21 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.525 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.514 HD13 HG23 ' A' ' 75' ' ' ILE . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.432 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 76' ' ' GLU . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' A' ' 75' ' ' ILE . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 76' ' ' GLU . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.517 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 97' ' ' THR . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 38' ' ' ILE . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.412 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 86' ' ' SER . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' ' OG1' ' A' ' 97' ' ' THR . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.425 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.424 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.425 ' CG2' HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 76' ' ' GLU . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 38' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 87' ' ' GLN . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.475 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 38' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 56' ' ' ILE . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 75' ' ' ILE . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 86' ' ' SER . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.491 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.412 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.529 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' SER . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.411 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.448 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 25' ' ' ILE . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.417 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.526 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.41 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 69' ' ' LYS . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.526 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 69' ' ' LYS . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 75' ' ' ILE . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.496 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' OG1' ' A' ' 97' ' ' THR . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.404 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 51' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.423 ' CD1' HG21 ' A' ' 77' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 86' ' ' SER . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.441 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' CE2' ' CB ' ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 38' ' ' ILE . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CG ' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.481 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 38' ' ' ILE . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 75' ' ' ILE . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.462 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -97.44 120.42 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 20' ' ' GLY . 2.1 p -83.9 159.8 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.457 ' N ' ' CG2' ' A' ' 19' ' ' VAL . . . 141.27 -168.95 25.24 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.466 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 150.22 30.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.412 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 135.41 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.03 46.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.87 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 p 69.59 -58.99 0.51 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -76.06 55.95 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 45.82 -142.32 4.53 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.973 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -28.29 67.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.3 48.75 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.79 -47.84 86.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.37 169.09 18.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.95 -55.22 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.413 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.16 -69.5 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m -163.05 109.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.506 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 86' ' ' SER . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.696 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.696 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' CD2' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.44 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.44 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -87.14 141.66 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -130.01 129.25 43.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -83.12 169.29 16.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -111.6 36.85 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 107.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.65 160.18 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . 129.89 169.28 12.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.492 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.8 141.55 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 137.45 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.98 -137.25 2.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -87.35 148.02 25.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.357 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 59.42 30.99 20.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.08 -119.7 8.15 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.536 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.46 -21.72 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.19 47.6 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.83 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.1 t -80.25 -69.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.31 154.65 19.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.994 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.66 -28.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.76 50.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.293 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.45 -42.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.545 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -160.18 110.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 51' ' ' ILE . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.536 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.4 pp0? -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 108' ' ' PHE . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' CG1' ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -106.23 127.18 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.25 134.22 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.93 -178.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.14 41.64 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.035 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.827 0.346 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -108.1 92.59 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.78 7.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 111.654 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.63 -172.68 32.02 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.59 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.1 153.44 32.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 25' ' ' ILE . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 144.72 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.05 45.46 0.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.902 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 47.3 29.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -152.87 43.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.47 -155.9 22.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.302 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 38' ' ' ILE . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.29 -32.97 74.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.32 55.63 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.21 -50.25 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 165.7 28.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.08 -39.19 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.154 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.48 -34.71 76.64 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.87 -143.5 14.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m 59.56 21.87 10.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 69' ' ' LYS . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 56' ' ' ILE . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.437 ' CG ' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.407 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.423 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -99.0 132.78 44.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -92.56 136.87 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.97 153.27 38.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.79 30.28 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.116 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.1 tptt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -167.9 65.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.2 160.03 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.989 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.46 127.87 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.654 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.87 159.28 37.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -51.5 119.86 4.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.56 -88.33 2.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.44 -48.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -85.01 57.48 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.75 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.68 -113.69 5.22 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.203 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -59.0 -25.02 63.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 63.83 52.14 2.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.4 t -77.82 -68.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.53 151.9 24.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.94 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.99 -42.1 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.956 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.29 32.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.543 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.69 -62.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.54 104.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.409 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -100.83 110.92 23.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 131.38 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.74 133.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -33.57 12.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.17 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -132.44 141.88 49.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 20' ' ' GLY . 2.1 p -80.51 159.63 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 19' ' ' VAL . . . 163.83 -139.26 5.76 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.644 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.69 170.84 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.401 HD11 ' CG2' ' A' ' 107' ' ' VAL . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -52.12 130.76 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.93 -117.45 2.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -84.75 57.52 4.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.731 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.87 -114.67 6.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.401 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -35.61 80.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 59.65 70.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.456 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.98 -49.18 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.636 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 162.41 36.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.288 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 mm -60.8 -37.4 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.811 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.26 56.62 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.564 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.02 -140.44 31.37 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.85 21.47 10.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.401 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.452 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.463 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 140.5 37.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.7 149.46 23.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.774 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.4 173.43 12.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -98.39 35.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.91 167.18 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 6.93 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.528 . . . . 0.0 111.477 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.29 148.8 20.17 Favored Glycine 0 C--N 1.316 -0.556 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.328 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -145.19 -177.44 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -56.44 117.59 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.31 -81.08 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.506 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -136.98 156.61 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.82 50.46 10.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.07 -103.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.499 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -60.19 -25.07 65.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 62.91 65.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.16 -45.8 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.85 166.74 23.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.93 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.59 -67.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.301 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.62 59.66 0.68 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.525 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.98 -105.33 1.36 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.55 104.94 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.402 HD12 HG21 ' A' ' 56' ' ' ILE . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.431 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' ' HA ' ' A' ' 76' ' ' GLU . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.403 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 86' ' ' SER . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 87' ' ' GLN . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.411 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.19 145.19 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.65 113.97 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.29 169.05 18.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 111.23 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.761 0.315 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.64 176.21 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 112' ' ' GLU . 2.2 p -84.11 159.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' N ' ' CG2' ' A' ' 19' ' ' VAL . . . 102.49 149.67 22.02 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.692 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 146.79 50.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp -55.3 144.16 25.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.5 55.04 0.3 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.811 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 48.64 29.83 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 111.434 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -144.04 35.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.0 -133.5 41.11 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.209 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.435 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 -59.71 -24.72 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.27 82.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.77 -66.66 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.07 161.29 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.013 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.63 113.26 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.34 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.27 25.59 26.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.63 -128.56 6.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.87 105.0 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 51' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.412 ' HA ' HG13 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.408 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.43 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.417 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.35 108.29 19.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -133.16 140.41 47.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.86 84.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.225 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 19' ' ' VAL . 2.5 tt0 -88.89 -27.92 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.616 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.447 -179.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.737 0.303 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.78 31.16 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 20' ' ' GLY . 1.4 p -110.66 -167.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' N ' HG11 ' A' ' 19' ' ' VAL . . . 116.43 174.35 17.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 149.51 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt -50.22 134.36 22.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.55 176.6 20.49 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.386 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -40.14 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -87.11 57.56 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.42 -143.68 41.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.408 ' CD2' HD21 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -30.63 69.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.38 73.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.251 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.0 -49.58 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.96 161.57 37.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.139 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.58 117.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.87 26.81 48.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.705 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.1 -133.72 6.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.2 105.71 16.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.494 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 HD21 ' CD2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' CE ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.481 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.46 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.8 145.03 34.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -89.2 156.53 18.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.32 -175.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.03 71.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -112.15 133.4 54.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 20' ' ' GLY . 0.6 OUTLIER -115.64 -164.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.452 ' N ' ' CG1' ' A' ' 19' ' ' VAL . . . 94.26 155.56 31.76 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.98 166.81 28.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 136.82 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.73 -136.84 3.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.86 -30.44 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.009 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.48 53.75 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.34 -131.11 51.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD13 ' CE1' ' A' ' 36' ' ' PHE . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CE1' HD13 ' A' ' 34' ' ' LEU . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -67.64 -27.9 67.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.13 50.89 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.13 -81.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 p -100.91 126.51 47.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.83 130.09 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.434 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.68 21.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.732 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.01 103.86 8.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 51' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 HG23 ' A' ' 56' ' ' ILE . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 52' ' ' TYR . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.419 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD21 ' CG1' ' A' ' 90' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' CG1' HD21 ' A' ' 82' ' ' LEU . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.404 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -97.78 145.11 26.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -113.69 140.8 47.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.82 159.37 16.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.65 34.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -142.26 139.82 32.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 t -132.02 160.22 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 150.99 165.24 12.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 143.14 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER -50.18 137.34 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.38 46.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.031 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 p 69.03 -58.7 0.49 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.91 56.7 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.954 0.407 . . . . 0.0 111.171 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.77 -135.05 25.68 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.663 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' CD1' HG12 ' A' ' 90' ' ' VAL . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.401 HG23 ' CA ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -53.55 -24.57 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.77 41.06 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 44' ' ' THR . 2.5 p -70.96 -46.56 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.042 0.449 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.456 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 6.0 t -162.91 172.57 14.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.998 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -66.75 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.132 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.5 76.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.45 -124.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.79 106.75 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' CA ' HG23 ' A' ' 39' ' ' THR . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 108' ' ' PHE . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 75' ' ' ILE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 82' ' ' LEU . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.448 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.406 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.448 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -127.57 143.95 51.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -66.25 149.81 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -85.22 165.91 16.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.47 72.86 5.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 61.05 166.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.7 160.0 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.148 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 108' ' ' PHE . . . 169.47 148.71 5.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 133.86 55.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp -56.45 137.43 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.85 -62.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.617 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -156.75 161.66 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 59.55 55.49 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.13 -128.67 46.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.431 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' CE1' HD11 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.43 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 HG21 ' CA ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -17.79 29.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.44 51.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.939 0.399 . . . . 0.0 110.781 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 t -86.95 -67.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.42 156.98 25.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.973 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.24 65.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.3 28.28 56.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.51 71.24 0.5 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.503 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.55 104.34 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' CA ' HG21 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.525 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.525 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.514 HD13 HG23 ' A' ' 75' ' ' ILE . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.5 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 76' ' ' GLU . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 20' ' ' GLY . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -102.84 104.76 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -72.74 139.11 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -109.1 110.27 21.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.52 -62.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 59.93 77.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.9 t -112.44 159.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.06 159.23 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 144.65 46.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.83 113.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -142.39 64.24 0.5 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 30' ' ' GLY . 13.3 t 49.12 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 111.296 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 55.37 34.94 23.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.42 -148.08 50.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.357 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -25.91 61.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.09 67.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.0 p -94.51 -45.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.466 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -125.43 168.77 13.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.968 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.37 -66.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.81 49.64 0.62 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.76 -102.7 2.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.59 105.71 8.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 76' ' ' GLU . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.517 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 95' ' ' ARG . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 97' ' ' THR . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -106.38 108.73 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.93 127.9 34.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -93.04 147.33 22.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.17 94.5 5.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.712 0.291 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 77.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.981 0.42 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.86 8.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.37 151.1 42.97 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.74 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -155.6 139.56 16.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -47.68 127.81 12.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.23 -84.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.585 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.53 159.17 43.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 57.37 66.29 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.037 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.42 -120.69 21.08 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 38' ' ' ILE . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 48.51 4.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.18 -71.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.995 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 p -102.68 147.1 27.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.011 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.71 -29.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.358 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.59 76.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.415 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.97 -83.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -132.34 120.27 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.412 ' CD1' HG21 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' O ' ' CB ' ' A' ' 86' ' ' SER . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' ' OG1' ' A' ' 97' ' ' THR . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.425 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.424 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.425 ' CG2' HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.405 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 76' ' ' GLU . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 145.12 36.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.03 117.25 20.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.777 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.45 -172.46 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -166.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.087 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -85.73 155.45 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.94 7.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.128 0.489 . . . . 0.0 111.599 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.54 175.34 34.91 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.56 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.67 141.25 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 120.82 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.04 -123.35 4.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -49.44 2.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.87 0.367 . . . . 0.0 110.995 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.17 57.3 4.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.94 -130.57 51.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.337 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 38' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.39 65.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 59.4 52.52 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.0 p -87.42 -46.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -104.0 149.09 25.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.37 -30.24 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.384 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 39.47 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.96 -90.19 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.33 109.83 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 87' ' ' GLN . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.475 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -109.06 141.08 41.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.92 139.32 30.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.91 145.94 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.31 94.67 3.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -104.56 31.94 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 t -143.32 160.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.02 162.82 11.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.666 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 151.87 32.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 107' ' ' VAL . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.82 127.18 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.57 -131.58 1.96 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.17 155.58 16.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.04 40.57 18.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.01 -124.21 34.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.601 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 38' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -62.89 -29.07 70.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.24 55.63 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.8 t -77.0 -70.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -103.61 143.42 32.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.927 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.86 -32.84 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.394 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 32.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.61 -92.61 2.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.56 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -148.23 107.74 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 56' ' ' ILE . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.425 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 75' ' ' ILE . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 86' ' ' SER . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.491 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.412 ' CG2' ' CD1' ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.21 143.7 44.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.14 143.62 31.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.631 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.87 156.4 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.047 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.44 -68.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -59.98 -175.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.76 6.63 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 111.547 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.43 142.67 11.87 Favored Glycine 0 C--N 1.314 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.311 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 -178.12 5.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.11 129.02 33.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.85 -72.13 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.3 p -160.04 -52.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -90.5 59.45 4.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.81 -136.57 51.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.384 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -30.98 69.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 59.68 69.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.8 t -73.64 -36.12 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.73 165.88 25.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.91 91.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.181 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.73 83.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.72 -115.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.07 106.53 14.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.594 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.529 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG2' ' CD2' ' A' ' 74' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' SER . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.411 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.404 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.448 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 145.21 26.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.0 152.05 51.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -129.45 178.67 6.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -104.61 -26.69 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.032 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.218 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.73 0.3 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 177.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -116.07 160.18 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.3 155.66 6.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' CD ' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -144.49 142.7 30.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' CD2' ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 25' ' ' ILE . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.417 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp -56.04 108.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.28 -96.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -158.61 29.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.983 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.06 41.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.29 -132.74 11.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.406 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.526 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.25 -24.88 30.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 62.57 56.5 2.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.95 -48.95 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 160.52 39.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.3 81.82 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.417 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.21 -23.32 32.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.791 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.04 -143.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.502 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 136.52 33.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.41 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 69' ' ' LYS . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.526 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HA ' HG13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 69' ' ' LYS . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 75' ' ' ILE . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.401 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.496 ' HA ' ' CD2' ' A' ' 93' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.496 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.499 ' O ' ' OG1' ' A' ' 97' ' ' THR . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.404 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.417 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -101.83 131.13 48.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 122.45 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.0 165.84 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.09 -172.66 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -110.21 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -96.42 159.35 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 59.68 158.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.554 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.14 138.44 26.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 121.22 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.73 -86.51 1.93 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.543 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.25 -55.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.72 58.05 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.613 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.33 40.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.045 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -32.43 72.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.36 61.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.8 t -62.75 -51.7 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.82 162.51 36.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.66 -26.25 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.298 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.0 -26.51 8.77 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.726 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.52 -26.6 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 104.89 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.423 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 51' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.423 ' CD1' HG21 ' A' ' 77' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.451 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 86' ' ' SER . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.41 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -103.16 135.3 45.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 117.72 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.57 157.7 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.43 121.24 11.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 mttm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 40.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.02 160.09 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.15 142.78 13.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -143.06 -171.74 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.59 140.15 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.66 -157.97 8.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 p -91.54 -32.33 15.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 53.26 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.023 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.73 -140.3 44.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.441 ' CB ' ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' CE2' ' CB ' ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 38' ' ' ILE . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -28.17 66.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 62.35 49.75 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.3 p -70.53 -46.55 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.053 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.461 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -109.03 159.1 17.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.844 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.41 -30.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.349 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.18 95.12 0.1 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.14 -38.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.49 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.44 105.73 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CG ' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 85' ' ' LYS . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.481 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -87.62 125.1 34.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.58 155.41 16.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 60.25 109.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 30.99 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.977 0.418 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.22 95.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.935 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 t -139.89 160.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.79 -140.45 8.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.534 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.87 145.18 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.84 132.85 32.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.0 -154.75 8.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.542 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.42 -40.09 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.956 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -91.07 50.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.74 -137.08 49.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 38' ' ' ILE . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -24.89 64.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.33 54.44 2.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.74 -38.93 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 t -139.54 170.2 16.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.69 -66.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.36 56.0 0.6 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.487 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.85 -108.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.9 t -105.6 143.09 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 75' ' ' ILE . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.462 ' CG2' ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.462 ' CG2' ' CG2' ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 115.8 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.55 138.92 35.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.37 146.05 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.69 -26.19 66.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.148 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.93 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 34' ' ' LEU . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' C ' HD12 ' A' ' 34' ' ' LEU . . . . . . . . 0 CA--C 1.517 0.207 0 CA-C-O 120.698 0.054 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 27' ' ' LEU . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 51' ' ' ILE . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 38' ' ' ILE . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 56' ' ' ILE . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' ND2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 p30 -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.73 HD23 ' CG2' ' A' ' 77' ' ' VAL . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.781 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.013 HG23 HD11 ' A' ' 82' ' ' LEU . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.013 HD11 HG23 ' A' ' 77' ' ' VAL . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HE2' HD22 ' A' ' 93' ' ' LEU . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.854 ' HA ' HD23 ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.721 HD23 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HE ' HG12 ' A' ' 91' ' ' VAL . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 26' ' ' GLN . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.781 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' ILE . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 23' ' ' LEU . 26.4 ttm-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 HD12 ' CG2' ' A' ' 107' ' ' VAL . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 34' ' ' LEU . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD13 ' HE1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.717 HG13 HG21 ' A' ' 90' ' ' VAL . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.694 HG11 HD11 ' A' ' 56' ' ' ILE . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.694 HD11 HG11 ' A' ' 53' ' ' VAL . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.894 ' HA ' HD13 ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.492 ' O ' HD12 ' A' ' 68' ' ' LEU . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.717 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.054 HG23 HD11 ' A' ' 82' ' ' LEU . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.654 ' CG ' HG13 ' A' ' 103' ' ' VAL . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.054 HD11 HG23 ' A' ' 77' ' ' VAL . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 91' ' ' VAL . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.958 HG12 ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.562 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.667 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.958 ' HD2' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 25' ' ' ILE . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB2' HD11 ' A' ' 23' ' ' LEU . 3.9 tpt180 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 68' ' ' LEU . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 34' ' ' LEU . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 27' ' ' LEU . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 74' ' ' LEU . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 90' ' ' VAL . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' ILE . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 HG11 ' A' ' 53' ' ' VAL . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' PRO . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 68' ' ' LEU . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.696 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.679 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.99 HG23 HD11 ' A' ' 82' ' ' LEU . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.485 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.99 HD11 HG23 ' A' ' 77' ' ' VAL . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' NZ ' HG11 ' A' ' 80' ' ' VAL . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.862 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.888 HG21 HG13 ' A' ' 51' ' ' ILE . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.921 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.921 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.679 HD23 ' HB ' ' A' ' 75' ' ' ILE . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD21 ' HD3' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD23 ' OD2' ' A' ' 65' ' ' ASP . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 27' ' ' LEU . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.834 HD11 HG22 ' A' ' 91' ' ' VAL . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.769 HG13 HG21 ' A' ' 90' ' ' VAL . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 56' ' ' ILE . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 39' ' ' THR . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.774 HD11 HG11 ' A' ' 53' ' ' VAL . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD2' HD23 ' A' ' 27' ' ' LEU . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB2' HG23 ' A' ' 25' ' ' ILE . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.037 HG23 HD11 ' A' ' 82' ' ' LEU . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.037 HD11 HG23 ' A' ' 77' ' ' VAL . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.836 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 87' ' ' GLN . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 77' ' ' VAL . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 68' ' ' LEU . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 105' ' ' LEU . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.55 HD22 ' HE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HE2' HD22 ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 56' ' ' ILE . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 HG11 ' A' ' 53' ' ' VAL . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.674 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' HG23 ' A' ' 25' ' ' ILE . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 68' ' ' LEU . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' CD ' ' A' ' 73' ' ' ARG . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.055 HG23 HD11 ' A' ' 82' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG12 ' HZ2' ' A' ' 85' ' ' LYS . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.055 HD11 HG23 ' A' ' 77' ' ' VAL . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.932 ' HE3' HD11 ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.859 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.932 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.825 ' HD2' HG12 ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' GLN . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.678 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' LEU . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 HD12 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.438 ' NH1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' ' 106' ' ' LEU . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.57 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.905 HD11 HG22 ' A' ' 91' ' ' VAL . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' HD1' ' A' ' 52' ' ' TYR . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 38' ' ' ILE . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.553 ' HD1' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 68' ' ' LEU . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.613 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 25' ' ' ILE . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.89 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 68' ' ' LEU . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 107' ' ' VAL . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.669 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.451 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 82' ' ' LEU . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.611 HG11 HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.983 HD22 HG13 ' A' ' 90' ' ' VAL . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.556 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.983 HG13 HD22 ' A' ' 82' ' ' LEU . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.905 HG22 HD11 ' A' ' 38' ' ' ILE . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 HG11 ' A' ' 80' ' ' VAL . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.922 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 26' ' ' GLN . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.585 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' ' 22' ' ' ARG . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 72' ' ' ASP . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' CE ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD21 ' CE ' ' A' ' 21' ' ' LYS . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 34' ' ' LEU . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HE2' HD13 ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.91 HD12 HG21 ' A' ' 51' ' ' ILE . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.91 HG21 HD12 ' A' ' 38' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 68' ' ' LEU . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 63' ' ' ILE . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 57' ' ' LEU . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.616 ' HB2' HG23 ' A' ' 25' ' ' ILE . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.729 ' C ' HD11 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 38' ' ' ILE . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 108' ' ' PHE . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.784 ' CG2' HD21 ' A' ' 82' ' ' LEU . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.784 HD21 ' CG2' ' A' ' 77' ' ' VAL . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.658 ' NZ ' HD23 ' A' ' 82' ' ' LEU . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.841 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 86' ' ' SER . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 86' ' ' SER . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HG3' HG12 ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.92 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.443 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.92 ' CG2' HG21 ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 25' ' ' ILE . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.64 ' HB2' HD11 ' A' ' 75' ' ' ILE . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.651 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 94' ' ' LEU . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 39' ' ' THR . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 56' ' ' ILE . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' ILE . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.895 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 68' ' ' LEU . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.935 HG23 HD23 ' A' ' 105' ' ' LEU . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.598 HD21 HG13 ' A' ' 103' ' ' VAL . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 90' ' ' VAL . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 82' ' ' LEU . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 77' ' ' VAL . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.614 HD13 HD12 ' A' ' 34' ' ' LEU . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.86 ' CD ' HG12 ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.087 HG21 HG22 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.481 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.087 HG22 HG21 ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.935 HD23 HG23 ' A' ' 77' ' ' VAL . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 75' ' ' ILE . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 25' ' ' ILE . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.723 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 94' ' ' LEU . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 HG22 ' A' ' 91' ' ' VAL . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 38' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.781 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HB2' HG23 ' A' ' 25' ' ' ILE . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.898 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.72 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.039 HG23 HD11 ' A' ' 82' ' ' LEU . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 77' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' OD2' ' A' ' 81' ' ' ASP . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 86' ' ' SER . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 87' ' ' GLN . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 34' ' ' LEU . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HG3' HG12 ' A' ' 91' ' ' VAL . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.03 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 26' ' ' GLN . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.03 ' CG2' HG21 ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.72 HD23 ' HB ' ' A' ' 75' ' ' ILE . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 23' ' ' LEU . 4.6 tpp85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.566 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.162 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 27' ' ' LEU . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HE1' HD13 ' A' ' 34' ' ' LEU . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 51' ' ' ILE . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.79 HG13 HG21 ' A' ' 90' ' ' VAL . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG11 HD11 ' A' ' 56' ' ' ILE . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HG11 ' A' ' 53' ' ' VAL . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' TYR . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.892 HG23 HD21 ' A' ' 82' ' ' LEU . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 85' ' ' LYS . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.892 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 80' ' ' VAL . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 51' ' ' ILE . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.817 ' CD ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.93 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.93 ' CG2' HG21 ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.491 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.619 HG22 HD12 ' A' ' 25' ' ' ILE . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 23' ' ' LEU . 14.4 ptp180 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.74 ' CE ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.846 HD12 HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 91' ' ' VAL . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 68' ' ' LEU . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' CA ' HG22 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 63' ' ' ILE . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.926 ' HA ' HD13 ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.491 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.926 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' CB ' HG23 ' A' ' 25' ' ' ILE . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.894 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' LEU . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.626 ' HB ' HD23 ' A' ' 106' ' ' LEU . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.537 ' OD1' HG13 ' A' ' 103' ' ' VAL . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.019 HD11 HG23 ' A' ' 77' ' ' VAL . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.872 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 86' ' ' SER . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 38' ' ' ILE . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.974 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.974 HG22 HG21 ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD23 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.626 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 23' ' ' LEU . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.603 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.87 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 94' ' ' LEU . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 91' ' ' VAL . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HA2' ' A' ' 84' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.487 HD12 ' OE1' ' A' ' 87' ' ' GLN . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 56' ' ' ILE . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.761 HD11 HG11 ' A' ' 53' ' ' VAL . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HA ' HD13 ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.495 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 25' ' ' ILE . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.87 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 68' ' ' LEU . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.847 ' HB3' HD12 ' A' ' 82' ' ' LEU . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 82' ' ' LEU . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 77' ' ' VAL . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' ' 85' ' ' LYS . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 77' ' ' VAL . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 48' ' ' SER . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 34' ' ' LEU . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HD3' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.909 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 23' ' ' LEU . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 25' ' ' ILE . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' HD11 ' A' ' 75' ' ' ILE . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.743 ' HD2' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD21 ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.681 HD12 ' CG2' ' A' ' 107' ' ' VAL . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.619 HD12 ' HE2' ' A' ' 36' ' ' PHE . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 34' ' ' LEU . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HE2' HD12 ' A' ' 27' ' ' LEU . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD11 HG22 ' A' ' 91' ' ' VAL . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 90' ' ' VAL . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 56' ' ' ILE . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.69 ' HA ' HD13 ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 25' ' ' ILE . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG12 ' HZ3' ' A' ' 85' ' ' LYS . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.909 ' HE3' HD11 ' A' ' 93' ' ' LEU . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 86' ' ' SER . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.842 HG12 ' HG3' ' A' ' 95' ' ' ARG . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.909 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 94' ' ' LEU . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.842 ' HG3' HG12 ' A' ' 91' ' ' VAL . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.789 HG21 HG22 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 26' ' ' GLN . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 75' ' ' ILE . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.681 ' CG2' HD12 ' A' ' 25' ' ' ILE . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.811 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.811 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.695 HD12 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.7 HD13 ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 51' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 38' ' ' ILE . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 56' ' ' ILE . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.795 HD11 HG11 ' A' ' 53' ' ' VAL . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.642 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD2' HD23 ' A' ' 27' ' ' LEU . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.657 ' HB2' HG23 ' A' ' 25' ' ' ILE . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.9 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 68' ' ' LEU . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 38' ' ' ILE . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.665 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HD11 ' A' ' 82' ' ' LEU . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG11 ' HE3' ' A' ' 85' ' ' LYS . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 77' ' ' VAL . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HE3' HG11 ' A' ' 80' ' ' VAL . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 86' ' ' SER . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.551 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.683 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.054 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.054 HG22 HG21 ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.695 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 75' ' ' ILE . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 68' ' ' LEU . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HE1' ' A' ' 36' ' ' PHE . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 72' ' ' ASP . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 53' ' ' VAL . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.717 ' HB2' HG23 ' A' ' 25' ' ' ILE . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 22' ' ' ARG . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.997 HG23 HD11 ' A' ' 82' ' ' LEU . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.997 HD11 HG23 ' A' ' 77' ' ' VAL . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.823 HG22 HD22 ' A' ' 82' ' ' LEU . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.641 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.055 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.055 HG22 HG21 ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.565 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.568 ' HD2' HD21 ' A' ' 106' ' ' LEU . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD23 ' A' ' 34' ' ' LEU . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 HD13 ' HE1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.845 HG21 ' CD1' ' A' ' 74' ' ' LEU . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' CG2' HD13 ' A' ' 38' ' ' ILE . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 68' ' ' LEU . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.412 HD11 HG11 ' A' ' 53' ' ' VAL . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HA ' HD13 ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB2' HG23 ' A' ' 25' ' ' ILE . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' N ' HD12 ' A' ' 68' ' ' LEU . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.845 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 82' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 77' ' ' VAL . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 93' ' ' LEU . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.85 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.1 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.582 HD11 ' NZ ' ' A' ' 85' ' ' LYS . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.032 HG21 HG22 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 77' ' ' VAL . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HD2' ' A' ' 22' ' ' ARG . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 25' ' ' ILE . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.462 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 106' ' ' LEU . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 68' ' ' LEU . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.421 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 34' ' ' LEU . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 27' ' ' LEU . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.844 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.786 HG13 HG21 ' A' ' 90' ' ' VAL . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 56' ' ' ILE . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.578 HD11 HG11 ' A' ' 53' ' ' VAL . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.805 ' HA ' HD13 ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.805 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.666 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 82' ' ' LEU . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 85' ' ' LYS . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.855 HD11 HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' CE ' HG11 ' A' ' 80' ' ' VAL . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG22 HD22 ' A' ' 82' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.659 HD21 ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 94' ' ' LEU . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.968 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.432 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.968 ' CG2' HG21 ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.421 ' CG2' HD12 ' A' ' 23' ' ' LEU . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' HB2' HD11 ' A' ' 75' ' ' ILE . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 27' ' ' LEU . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HE1' HD22 ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.939 HD12 HG21 ' A' ' 51' ' ' ILE . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.939 HG21 HD12 ' A' ' 38' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 56' ' ' ILE . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.706 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 25' ' ' ILE . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.91 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' HD12 ' A' ' 68' ' ' LEU . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.648 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 76' ' ' GLU . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 75' ' ' ILE . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.807 HG23 HD11 ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 HG22 ' A' ' 90' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.849 HG22 HD22 ' A' ' 82' ' ' LEU . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.82 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.951 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.951 ' CG2' HG21 ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.559 HD23 HG13 ' A' ' 77' ' ' VAL . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.648 HG21 ' OD2' ' A' ' 72' ' ' ASP . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' NZ ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.614 HD13 ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.614 ' CE2' HD13 ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 74' ' ' LEU . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 90' ' ' VAL . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 56' ' ' ILE . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD11 HG11 ' A' ' 53' ' ' VAL . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.857 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.586 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG13 ' A' ' 103' ' ' VAL . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' CG1' ' HE2' ' A' ' 85' ' ' LYS . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 77' ' ' VAL . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 86' ' ' SER . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.027 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 26' ' ' GLN . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.672 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 25' ' ' ILE . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.814 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.5 tpt180 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.707 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' CD ' ' A' ' 21' ' ' LYS . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.666 HD12 ' HE1' ' A' ' 36' ' ' PHE . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 91' ' ' VAL . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.934 HG11 HD11 ' A' ' 56' ' ' ILE . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CA ' HG22 ' A' ' 39' ' ' THR . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.934 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HA ' HD13 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.668 ' HB2' HG23 ' A' ' 25' ' ' ILE . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.513 ' O ' HD12 ' A' ' 68' ' ' LEU . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 75' ' ' ILE . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.016 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.016 HG22 HG21 ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 75' ' ' ILE . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -97.44 120.42 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 20' ' ' GLY . 2.1 p -83.9 159.8 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 141.27 -168.95 25.24 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.466 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.52 150.22 30.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.93 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 34' ' ' LEU . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -49.79 135.41 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' C ' HG23 ' A' ' 31' ' ' THR . . . -139.03 46.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.87 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 30' ' ' GLY . 1.6 p 69.59 -58.99 0.51 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -76.06 55.95 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 45.82 -142.32 4.53 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.973 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 27' ' ' LEU . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 51' ' ' ILE . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -59.7 -28.29 67.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.3 48.75 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 46.5 t -64.79 -47.84 86.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.37 169.09 18.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.95 -55.22 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.413 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.16 -69.5 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m -163.05 109.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 43' ' ' VAL . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 38' ' ' ILE . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 56' ' ' ILE . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' ND2' ' HG3' ' A' ' 54' ' ' LYS . 7.6 p30 -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.73 HD23 ' CG2' ' A' ' 77' ' ' VAL . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.781 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.013 HG23 HD11 ' A' ' 82' ' ' LEU . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.013 HD11 HG23 ' A' ' 77' ' ' VAL . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HE2' HD22 ' A' ' 93' ' ' LEU . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.854 ' HA ' HD23 ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.721 HD23 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HE ' HG12 ' A' ' 91' ' ' VAL . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 26' ' ' GLN . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.781 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' ILE . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 23' ' ' LEU . 26.4 ttm-85 -87.14 141.66 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -130.01 129.25 43.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -83.12 169.29 16.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -111.6 36.85 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 107.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 20' ' ' GLY . 15.7 t -126.65 160.18 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 129.89 169.28 12.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.492 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.8 141.55 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 HD12 ' CG2' ' A' ' 107' ' ' VAL . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 34' ' ' LEU . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 137.45 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.98 -137.25 2.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -87.35 148.02 25.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.357 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 59.42 30.99 20.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.08 -119.7 8.15 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD13 ' HE1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -57.46 -21.72 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.19 47.6 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.83 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 41' ' ' ARG . 48.1 t -80.25 -69.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.31 154.65 19.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.994 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.66 -28.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.76 50.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.293 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.45 -42.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.545 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -160.18 110.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.717 HG13 HG21 ' A' ' 90' ' ' VAL . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.694 HG11 HD11 ' A' ' 56' ' ' ILE . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD11 HG11 ' A' ' 53' ' ' VAL . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.894 ' HA ' HD13 ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.492 ' O ' HD12 ' A' ' 68' ' ' LEU . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.717 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.054 HG23 HD11 ' A' ' 82' ' ' LEU . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.654 ' CG ' HG13 ' A' ' 103' ' ' VAL . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.054 HD11 HG23 ' A' ' 77' ' ' VAL . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 91' ' ' VAL . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.958 HG12 ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.667 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.958 ' HD2' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 25' ' ' ILE . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB2' HD11 ' A' ' 23' ' ' LEU . 3.9 tpt180 -106.23 127.18 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.25 134.22 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.93 -178.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.14 41.64 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.035 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.827 0.346 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -108.1 92.59 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.1 t -127.78 7.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 111.654 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.63 -172.68 32.02 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.59 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.1 153.44 32.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 68' ' ' LEU . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 34' ' ' LEU . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 144.72 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.05 45.46 0.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.902 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.723 HG23 ' HB3' ' A' ' 99' ' ' MET . 0.5 OUTLIER 47.3 29.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -152.87 43.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.47 -155.9 22.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.302 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 27' ' ' LEU . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 74' ' ' LEU . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.29 -32.97 74.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.32 55.63 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 50' ' ' PRO . 55.4 t -56.21 -50.25 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 165.7 28.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.08 -39.19 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.154 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.48 -34.71 76.64 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.87 -143.5 14.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m 59.56 21.87 10.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 43' ' ' VAL . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 90' ' ' VAL . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' ILE . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.8 p30 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 HG11 ' A' ' 53' ' ' VAL . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' PRO . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 68' ' ' LEU . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.696 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.679 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.99 HG23 HD11 ' A' ' 82' ' ' LEU . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.485 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.99 HD11 HG23 ' A' ' 77' ' ' VAL . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' NZ ' HG11 ' A' ' 80' ' ' VAL . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.862 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.888 HG21 HG13 ' A' ' 51' ' ' ILE . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.921 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.723 ' HB3' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.921 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.679 HD23 ' HB ' ' A' ' 75' ' ' ILE . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -99.0 132.78 44.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -92.56 136.87 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.97 153.27 38.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.79 30.28 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.116 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.1 tptt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -167.9 65.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 20' ' ' GLY . 18.2 t -142.2 160.03 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.989 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 132.46 127.87 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.654 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.87 159.28 37.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD21 ' HD3' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD23 ' OD2' ' A' ' 65' ' ' ASP . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -51.5 119.86 4.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.56 -88.33 2.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.44 -48.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -85.01 57.48 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.75 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.68 -113.69 5.22 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.203 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 27' ' ' LEU . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.834 HD11 HG22 ' A' ' 91' ' ' VAL . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -59.0 -25.02 63.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 63.83 52.14 2.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 50' ' ' PRO . 47.4 t -77.82 -68.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.53 151.9 24.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.94 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.99 -42.1 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.956 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.29 32.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.543 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.69 -62.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.54 104.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 43' ' ' VAL . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG13 HG21 ' A' ' 90' ' ' VAL . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 56' ' ' ILE . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 39' ' ' THR . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.774 HD11 HG11 ' A' ' 53' ' ' VAL . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD2' HD23 ' A' ' 27' ' ' LEU . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB2' HG23 ' A' ' 25' ' ' ILE . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.037 HG23 HD11 ' A' ' 82' ' ' LEU . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.037 HD11 HG23 ' A' ' 77' ' ' VAL . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.836 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 87' ' ' GLN . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 77' ' ' VAL . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -100.83 110.92 23.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 131.38 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.74 133.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -33.57 12.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.17 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -132.44 141.88 49.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 20' ' ' GLY . 2.1 p -80.51 159.63 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 163.83 -139.26 5.76 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.644 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -174.69 170.84 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 68' ' ' LEU . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 105' ' ' LEU . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -52.12 130.76 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.93 -117.45 2.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -84.75 57.52 4.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.731 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.87 -114.67 6.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.55 HD22 ' HE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HE2' HD22 ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.19 -35.61 80.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 59.65 70.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.456 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 46.4 t -69.98 -49.18 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.636 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 162.41 36.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.288 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 mm -60.8 -37.4 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.811 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.26 56.62 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.564 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.02 -140.44 31.37 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.85 21.47 10.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 43' ' ' VAL . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 56' ' ' ILE . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 HG11 ' A' ' 53' ' ' VAL . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.674 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' HG23 ' A' ' 25' ' ' ILE . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 68' ' ' LEU . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' CD ' ' A' ' 73' ' ' ARG . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.055 HG23 HD11 ' A' ' 82' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG12 ' HZ2' ' A' ' 85' ' ' LYS . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.055 HD11 HG23 ' A' ' 77' ' ' VAL . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.932 ' HE3' HD11 ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.859 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.932 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.825 ' HD2' HG12 ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' GLN . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.678 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' LEU . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 HD12 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' NH1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.22 140.5 37.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.7 149.46 23.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.774 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.4 173.43 12.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -98.39 35.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.91 167.18 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.4 t -108.72 6.93 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.528 . . . . 0.0 111.477 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.29 148.8 20.17 Favored Glycine 0 C--N 1.316 -0.556 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.328 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -145.19 -177.44 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' ' 106' ' ' LEU . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.57 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -56.44 117.59 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.31 -81.08 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.506 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -136.98 156.61 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.82 50.46 10.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.07 -103.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.499 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.905 HD11 HG22 ' A' ' 91' ' ' VAL . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' HD1' ' A' ' 52' ' ' TYR . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -60.19 -25.07 65.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 62.91 65.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' HD2' ' A' ' 50' ' ' PRO . 39.5 t -76.16 -45.8 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.85 166.74 23.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.93 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.59 -67.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.301 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.62 59.66 0.68 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.525 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.98 -105.33 1.36 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.55 104.94 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 43' ' ' VAL . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 38' ' ' ILE . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.553 ' HD1' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 68' ' ' LEU . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.613 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 25' ' ' ILE . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.89 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 68' ' ' LEU . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 107' ' ' VAL . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.669 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.451 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 82' ' ' LEU . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.611 HG11 HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.983 HD22 HG13 ' A' ' 90' ' ' VAL . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.556 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.983 HG13 HD22 ' A' ' 82' ' ' LEU . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.905 HG22 HD11 ' A' ' 38' ' ' ILE . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 HG11 ' A' ' 80' ' ' VAL . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.922 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 26' ' ' GLN . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.585 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' ' 22' ' ' ARG . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 72' ' ' ASP . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.19 145.19 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.65 113.97 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.29 169.05 18.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 111.23 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.761 0.315 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.64 176.21 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 112' ' ' GLU . 2.2 p -84.11 159.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 102.49 149.67 22.02 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.692 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' CE ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.62 146.79 50.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD21 ' CE ' ' A' ' 21' ' ' LYS . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 34' ' ' LEU . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp -55.3 144.16 25.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.5 55.04 0.3 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.811 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.848 HG23 ' HG2' ' A' ' 99' ' ' MET . 0.1 OUTLIER 48.64 29.83 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 111.434 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -144.04 35.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.0 -133.5 41.11 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.209 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HE2' HD13 ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.91 HD12 HG21 ' A' ' 51' ' ' ILE . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 -59.71 -24.72 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.27 82.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 23.6 t -104.77 -66.66 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.07 161.29 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.013 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.63 113.26 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.34 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.27 25.59 26.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.63 -128.56 6.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.87 105.0 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.91 HG21 HD12 ' A' ' 38' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 68' ' ' LEU . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 63' ' ' ILE . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 57' ' ' LEU . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.616 ' HB2' HG23 ' A' ' 25' ' ' ILE . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.729 ' C ' HD11 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 38' ' ' ILE . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 108' ' ' PHE . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.784 ' CG2' HD21 ' A' ' 82' ' ' LEU . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.784 HD21 ' CG2' ' A' ' 77' ' ' VAL . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.658 ' NZ ' HD23 ' A' ' 82' ' ' LEU . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.841 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 86' ' ' SER . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 86' ' ' SER . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HG3' HG12 ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.92 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.92 ' CG2' HG21 ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 25' ' ' ILE . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.64 ' HB2' HD11 ' A' ' 75' ' ' ILE . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.35 108.29 19.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.447 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -133.16 140.41 47.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.86 84.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.225 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HB2' HG11 ' A' ' 19' ' ' VAL . 2.5 tt0 -88.89 -27.92 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.616 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.447 -179.819 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.737 0.303 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.78 31.16 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.4 p -110.66 -167.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 19' ' ' VAL . . . 116.43 174.35 17.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.651 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.06 149.51 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt -50.22 134.36 22.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.55 176.6 20.49 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.386 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -40.14 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -87.11 57.56 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.42 -143.68 41.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 94' ' ' LEU . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.29 -30.63 69.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.38 73.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.251 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.649 HG23 ' HD2' ' A' ' 50' ' ' PRO . 39.1 t -70.0 -49.58 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.69 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.519 HG23 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -141.96 161.57 37.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.139 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.58 117.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.87 26.81 48.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.705 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 44' ' ' THR . . . -112.1 -133.72 6.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.497 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.2 105.71 16.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' HG23 ' A' ' 43' ' ' VAL . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 43' ' ' VAL . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 39' ' ' THR . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 56' ' ' ILE . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' ILE . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.895 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 68' ' ' LEU . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.935 HG23 HD23 ' A' ' 105' ' ' LEU . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.598 HD21 HG13 ' A' ' 103' ' ' VAL . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 90' ' ' VAL . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 82' ' ' LEU . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 77' ' ' VAL . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.614 HD13 HD12 ' A' ' 34' ' ' LEU . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.86 ' CD ' HG12 ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.087 HG21 HG22 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.481 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.087 HG22 HG21 ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.935 HD23 HG23 ' A' ' 77' ' ' VAL . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 75' ' ' ILE . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 25' ' ' ILE . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.723 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -107.8 145.03 34.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -89.2 156.53 18.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.32 -175.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.03 71.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -112.15 133.4 54.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 20' ' ' GLY . 0.6 OUTLIER -115.64 -164.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.692 ' N ' HG13 ' A' ' 19' ' ' VAL . . . 94.26 155.56 31.76 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -149.98 166.81 28.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 136.82 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.73 -136.84 3.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.86 -30.44 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.009 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.48 53.75 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.34 -131.11 51.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 94' ' ' LEU . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 HG22 ' A' ' 91' ' ' VAL . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -67.64 -27.9 67.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.13 50.89 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.653 HG23 ' HD2' ' A' ' 50' ' ' PRO . 48.6 t -60.13 -81.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 43' ' ' VAL . 6.9 p -100.91 126.51 47.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.83 130.09 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.434 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.68 21.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.732 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.01 103.86 8.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 43' ' ' VAL . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 38' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.781 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HB2' HG23 ' A' ' 25' ' ' ILE . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.898 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.72 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.039 HG23 HD11 ' A' ' 82' ' ' LEU . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 77' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' OD2' ' A' ' 81' ' ' ASP . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 86' ' ' SER . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 87' ' ' GLN . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 34' ' ' LEU . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HG3' HG12 ' A' ' 91' ' ' VAL . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.03 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 26' ' ' GLN . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.03 ' CG2' HG21 ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.72 HD23 ' HB ' ' A' ' 75' ' ' ILE . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 23' ' ' LEU . 4.6 tpp85 -97.78 145.11 26.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -113.69 140.8 47.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.82 159.37 16.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.65 34.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -142.26 139.82 32.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.9 t -132.02 160.22 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 150.99 165.24 12.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.558 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.566 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -140.74 143.14 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER -50.18 137.34 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.38 46.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.031 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.681 HG22 ' CG ' ' A' ' 99' ' ' MET . 2.4 p 69.03 -58.7 0.49 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.91 56.7 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.954 0.407 . . . . 0.0 111.171 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.77 -135.05 25.68 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.663 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 27' ' ' LEU . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HE1' HD13 ' A' ' 34' ' ' LEU . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 51' ' ' ILE . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -53.55 -24.57 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.77 41.06 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 44' ' ' THR . 2.5 p -70.96 -46.56 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.042 0.449 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.967 HG22 HG13 ' A' ' 43' ' ' VAL . 6.0 t -162.91 172.57 14.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.998 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -66.75 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.132 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.5 76.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.45 -124.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.79 106.75 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.624 ' HB2' HG12 ' A' ' 43' ' ' VAL . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.79 HG13 HG21 ' A' ' 90' ' ' VAL . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG11 HD11 ' A' ' 56' ' ' ILE . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HG11 ' A' ' 53' ' ' VAL . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' TYR . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.892 HG23 HD21 ' A' ' 82' ' ' LEU . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 85' ' ' LYS . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.892 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 80' ' ' VAL . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 51' ' ' ILE . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.817 ' CD ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.93 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.681 ' CG ' HG22 ' A' ' 31' ' ' THR . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.93 ' CG2' HG21 ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.491 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.619 HG22 HD12 ' A' ' 25' ' ' ILE . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 23' ' ' LEU . 14.4 ptp180 -127.57 143.95 51.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -66.25 149.81 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -85.22 165.91 16.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.47 72.86 5.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 61.05 166.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.3 t -91.7 160.0 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 169.47 148.71 5.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.74 ' CE ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.61 133.86 55.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.846 HD12 HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' A' ' 24' ' ' ASN . 0.5 OUTLIER -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp -56.45 137.43 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' THR . . . -149.85 -62.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 30' ' ' GLY . 1.5 p -156.75 161.66 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 59.55 55.49 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.13 -128.67 46.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.431 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 91' ' ' VAL . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -59.12 -17.79 29.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.44 51.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.939 0.399 . . . . 0.0 110.781 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 50' ' ' PRO . 34.1 t -86.95 -67.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.42 156.98 25.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.973 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.24 65.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.3 28.28 56.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.51 71.24 0.5 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.503 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.55 104.34 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.571 ' HD2' HG21 ' A' ' 43' ' ' VAL . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 68' ' ' LEU . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' CA ' HG22 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 63' ' ' ILE . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.926 ' HA ' HD13 ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.926 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' CB ' HG23 ' A' ' 25' ' ' ILE . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.894 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' LEU . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.626 ' HB ' HD23 ' A' ' 106' ' ' LEU . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.537 ' OD1' HG13 ' A' ' 103' ' ' VAL . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.019 HD11 HG23 ' A' ' 77' ' ' VAL . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.872 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 86' ' ' SER . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 38' ' ' ILE . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.974 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.974 HG22 HG21 ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD23 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.626 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 23' ' ' LEU . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -102.84 104.76 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -72.74 139.11 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -109.1 110.27 21.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.52 -62.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 59.93 77.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.9 t -112.44 159.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 63.06 159.23 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.603 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -135.67 144.65 46.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.87 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.83 113.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 31' ' ' THR . . . -142.39 64.24 0.5 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 30' ' ' GLY . 13.3 t 49.12 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 111.296 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 7.0 mt-10 55.37 34.94 23.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.42 -148.08 50.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.357 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 94' ' ' LEU . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 91' ' ' VAL . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -25.91 61.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.09 67.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 44' ' ' THR . 3.0 p -94.51 -45.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.595 HG22 ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -125.43 168.77 13.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.968 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.37 -66.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.81 49.64 0.62 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.76 -102.7 2.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HA2' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -126.59 105.71 8.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.487 HD12 ' OE1' ' A' ' 87' ' ' GLN . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 56' ' ' ILE . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.761 HD11 HG11 ' A' ' 53' ' ' VAL . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HA ' HD13 ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.495 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 25' ' ' ILE . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.87 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 68' ' ' LEU . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.847 ' HB3' HD12 ' A' ' 82' ' ' LEU . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 82' ' ' LEU . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 77' ' ' VAL . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' ' 85' ' ' LYS . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 77' ' ' VAL . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 48' ' ' SER . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 34' ' ' LEU . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HD3' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.909 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 23' ' ' LEU . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 25' ' ' ILE . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' HD11 ' A' ' 75' ' ' ILE . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -106.38 108.73 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.93 127.9 34.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -93.04 147.33 22.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.17 94.5 5.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.712 0.291 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 77.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.981 0.42 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.9 t -128.86 8.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.37 151.1 42.97 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.74 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.743 ' HD2' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -155.6 139.56 16.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD21 ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.681 HD12 ' CG2' ' A' ' 107' ' ' VAL . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.619 HD12 ' HE2' ' A' ' 36' ' ' PHE . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -47.68 127.81 12.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.23 -84.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.585 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.53 159.17 43.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 57.37 66.29 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.037 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.42 -120.69 21.08 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 34' ' ' LEU . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HE2' HD12 ' A' ' 27' ' ' LEU . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD11 HG22 ' A' ' 91' ' ' VAL . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HD3' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 48.51 4.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 50' ' ' PRO . 61.6 t -61.18 -71.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.995 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 p -102.68 147.1 27.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.011 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.71 -29.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.358 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.59 76.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.415 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.97 -83.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -132.34 120.27 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 43' ' ' VAL . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 90' ' ' VAL . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 56' ' ' ILE . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.69 ' HA ' HD13 ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 25' ' ' ILE . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG12 ' HZ3' ' A' ' 85' ' ' LYS . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.909 ' HE3' HD11 ' A' ' 93' ' ' LEU . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 86' ' ' SER . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.842 HG12 ' HG3' ' A' ' 95' ' ' ARG . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.909 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 94' ' ' LEU . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.842 ' HG3' HG12 ' A' ' 91' ' ' VAL . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.789 HG21 HG22 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 26' ' ' GLN . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 75' ' ' ILE . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.681 ' CG2' HD12 ' A' ' 25' ' ' ILE . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 145.12 36.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.03 117.25 20.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.777 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.45 -172.46 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -166.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.087 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -85.73 155.45 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.6 t -97.94 7.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.128 0.489 . . . . 0.0 111.599 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.54 175.34 34.91 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.56 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.811 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -166.67 141.25 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.811 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.695 HD12 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 120.82 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.04 -123.35 4.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -49.44 2.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.87 0.367 . . . . 0.0 110.995 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.17 57.3 4.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.94 -130.57 51.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.337 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.7 HD13 ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 51' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.39 65.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 59.4 52.52 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.0 p -87.42 -46.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -104.0 149.09 25.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.37 -30.24 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.384 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 39.47 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.96 -90.19 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.33 109.83 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 38' ' ' ILE . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 56' ' ' ILE . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.795 HD11 HG11 ' A' ' 53' ' ' VAL . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.642 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD2' HD23 ' A' ' 27' ' ' LEU . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.657 ' HB2' HG23 ' A' ' 25' ' ' ILE . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.9 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 68' ' ' LEU . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 38' ' ' ILE . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.665 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HD11 ' A' ' 82' ' ' LEU . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG11 ' HE3' ' A' ' 85' ' ' LYS . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 77' ' ' VAL . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HE3' HG11 ' A' ' 80' ' ' VAL . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 86' ' ' SER . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.551 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.683 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.054 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.054 HG22 HG21 ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.695 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -109.06 141.08 41.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.92 139.32 30.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.91 145.94 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.31 94.67 3.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -104.56 31.94 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 20' ' ' GLY . 17.8 t -143.32 160.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 125.02 162.82 11.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.666 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.52 151.87 32.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 75' ' ' ILE . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 68' ' ' LEU . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -51.82 127.18 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.57 -131.58 1.96 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.17 155.58 16.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.04 40.57 18.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.01 -124.21 34.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.601 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HE1' ' A' ' 36' ' ' PHE . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -62.89 -29.07 70.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.24 55.63 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 50' ' ' PRO . 54.8 t -77.0 -70.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -103.61 143.42 32.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.927 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.86 -32.84 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.394 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 32.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.61 -92.61 2.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.56 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -148.23 107.74 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 43' ' ' VAL . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 72' ' ' ASP . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 53' ' ' VAL . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.717 ' HB2' HG23 ' A' ' 25' ' ' ILE . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 22' ' ' ARG . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.997 HG23 HD11 ' A' ' 82' ' ' LEU . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.997 HD11 HG23 ' A' ' 77' ' ' VAL . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.823 HG22 HD22 ' A' ' 82' ' ' LEU . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.641 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.055 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.055 HG22 HG21 ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.565 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -115.21 143.7 44.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.14 143.62 31.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.631 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.87 156.4 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.047 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.44 -68.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -59.98 -175.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.6 t -108.76 6.63 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 111.547 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.43 142.67 11.87 Favored Glycine 0 C--N 1.314 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.311 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 -178.12 5.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.568 ' HD2' HD21 ' A' ' 106' ' ' LEU . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD23 ' A' ' 34' ' ' LEU . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.11 129.02 33.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 31' ' ' THR . . . -110.85 -72.13 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' GLY . 1.3 p -160.04 -52.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -90.5 59.45 4.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.81 -136.57 51.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.384 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD13 ' HE1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.845 HG21 ' CD1' ' A' ' 74' ' ' LEU . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -30.98 69.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 59.68 69.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG23 ' HD2' ' A' ' 50' ' ' PRO . 31.8 t -73.64 -36.12 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -137.73 165.88 25.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.91 91.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.181 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.73 83.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.72 -115.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 44' ' ' THR . 0.4 OUTLIER -83.07 106.53 14.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 43' ' ' VAL . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' CG2' HD13 ' A' ' 38' ' ' ILE . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 68' ' ' LEU . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.412 HD11 HG11 ' A' ' 53' ' ' VAL . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HA ' HD13 ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB2' HG23 ' A' ' 25' ' ' ILE . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' N ' HD12 ' A' ' 68' ' ' LEU . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.845 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 82' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 77' ' ' VAL . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 93' ' ' LEU . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.85 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.1 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.582 HD11 ' NZ ' ' A' ' 85' ' ' LYS . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.032 HG21 HG22 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 77' ' ' VAL . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HD2' ' A' ' 22' ' ' ARG . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 25' ' ' ILE . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 145.21 26.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.0 152.05 51.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -129.45 178.67 6.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -104.61 -26.69 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.032 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.218 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.73 0.3 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 177.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 20' ' ' GLY . 16.5 t -116.07 160.18 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 147.3 155.66 6.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -144.49 142.7 30.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 106' ' ' LEU . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 68' ' ' LEU . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.421 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 34' ' ' LEU . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp -56.04 108.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.28 -96.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 99' ' ' MET . 14.5 t -158.61 29.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.06 41.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 81.29 -132.74 11.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.406 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 27' ' ' LEU . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.844 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HD3' HG22 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -55.25 -24.88 30.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 62.57 56.5 2.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 41' ' ' ARG . 22.1 t -75.95 -48.95 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 160.52 39.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.3 81.82 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.417 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.21 -23.32 32.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.791 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.04 -143.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.502 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 136.52 33.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.786 HG13 HG21 ' A' ' 90' ' ' VAL . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 56' ' ' ILE . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.578 HD11 HG11 ' A' ' 53' ' ' VAL . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.805 ' HA ' HD13 ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.805 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.666 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 82' ' ' LEU . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 85' ' ' LYS . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.855 HD11 HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' CE ' HG11 ' A' ' 80' ' ' VAL . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG22 HD22 ' A' ' 82' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.659 HD21 ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 94' ' ' LEU . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.968 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.432 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.968 ' CG2' HG21 ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.421 ' CG2' HD12 ' A' ' 23' ' ' LEU . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' HB2' HD11 ' A' ' 75' ' ' ILE . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -101.83 131.13 48.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 122.45 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.0 165.84 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.09 -172.66 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -110.21 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.3 t -96.42 159.35 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 59.68 158.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.554 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.14 138.44 26.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 121.22 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.73 -86.51 1.93 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.543 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.25 -55.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.72 58.05 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.613 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.33 40.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.045 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 27' ' ' LEU . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HE1' HD22 ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.939 HD12 HG21 ' A' ' 51' ' ' ILE . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -32.43 72.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.36 61.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.69 HG23 ' HD2' ' A' ' 50' ' ' PRO . 42.8 t -62.75 -51.7 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.82 162.51 36.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.66 -26.25 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.298 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.0 -26.51 8.77 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.726 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.52 -26.6 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 104.89 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 43' ' ' VAL . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.939 HG21 HD12 ' A' ' 38' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 56' ' ' ILE . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.706 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 25' ' ' ILE . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.91 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' HD12 ' A' ' 68' ' ' LEU . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.648 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 76' ' ' GLU . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 75' ' ' ILE . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.807 HG23 HD11 ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 HG22 ' A' ' 90' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.849 HG22 HD22 ' A' ' 82' ' ' LEU . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.82 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.951 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.951 ' CG2' HG21 ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.559 HD23 HG13 ' A' ' 77' ' ' VAL . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.648 HG21 ' OD2' ' A' ' 72' ' ' ASP . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -103.16 135.3 45.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 117.72 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.57 157.7 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.43 121.24 11.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 mttm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 40.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.6 t -133.02 160.09 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 100.15 142.78 13.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' NZ ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -143.06 -171.74 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.59 140.15 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.66 -157.97 8.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 p -91.54 -32.33 15.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 53.26 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.023 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.73 -140.3 44.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD13 ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' CE2' HD13 ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 74' ' ' LEU . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -28.17 66.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 62.35 49.75 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.3 p -70.53 -46.55 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.053 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.461 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -109.03 159.1 17.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.844 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.41 -30.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.349 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.18 95.12 0.1 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.14 -38.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.49 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.44 105.73 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 90' ' ' VAL . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 56' ' ' ILE . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD11 HG11 ' A' ' 53' ' ' VAL . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.857 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.586 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG13 ' A' ' 103' ' ' VAL . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' CG1' ' HE2' ' A' ' 85' ' ' LYS . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 77' ' ' VAL . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 86' ' ' SER . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.027 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 26' ' ' GLN . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.672 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 25' ' ' ILE . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.814 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.5 tpt180 -87.62 125.1 34.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.58 155.41 16.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HA ' HG11 ' A' ' 19' ' ' VAL . 17.1 tt0 60.25 109.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 30.99 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.977 0.418 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.22 95.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.935 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 20' ' ' GLY . 16.1 t -139.89 160.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 147.79 -140.45 8.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.534 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.707 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -160.87 145.18 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' CD ' ' A' ' 21' ' ' LYS . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -51.84 132.85 32.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.0 -154.75 8.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.542 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.42 -40.09 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.956 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -91.07 50.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.74 -137.08 49.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.666 HD12 ' HE1' ' A' ' 36' ' ' PHE . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 91' ' ' VAL . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -24.89 64.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.33 54.44 2.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 41.3 t -67.74 -38.93 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 48' ' ' SER . 1.1 t -139.54 170.2 16.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.69 -66.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.36 56.0 0.6 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.487 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.85 -108.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 44' ' ' THR . 27.9 t -105.6 143.09 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.934 HG11 HD11 ' A' ' 56' ' ' ILE . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CA ' HG22 ' A' ' 39' ' ' THR . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.934 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HA ' HD13 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.668 ' HB2' HG23 ' A' ' 25' ' ' ILE . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.513 ' O ' HD12 ' A' ' 68' ' ' LEU . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 75' ' ' ILE . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.016 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.016 HG22 HG21 ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 75' ' ' ILE . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.85 115.8 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.55 138.92 35.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.37 146.05 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.69 -26.19 66.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.148 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.93 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 34' ' ' LEU . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' C ' HD12 ' A' ' 34' ' ' LEU . . . . . . . . 0 CA--C 1.517 0.207 0 CA-C-O 120.698 0.054 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 27' ' ' LEU . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 51' ' ' ILE . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 41' ' ' ARG . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 38' ' ' ILE . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 56' ' ' ILE . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.73 HD23 ' CG2' ' A' ' 77' ' ' VAL . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.781 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.013 HG23 HD11 ' A' ' 82' ' ' LEU . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.013 HD11 HG23 ' A' ' 77' ' ' VAL . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HE2' HD22 ' A' ' 93' ' ' LEU . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.854 ' HA ' HD23 ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.721 HD23 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HE ' HG12 ' A' ' 91' ' ' VAL . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 26' ' ' GLN . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.781 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' ILE . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 23' ' ' LEU . 26.4 ttm-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 HD12 ' CG2' ' A' ' 107' ' ' VAL . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 34' ' ' LEU . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD13 ' HE1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.717 HG13 HG21 ' A' ' 90' ' ' VAL . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.694 HG11 HD11 ' A' ' 56' ' ' ILE . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.694 HD11 HG11 ' A' ' 53' ' ' VAL . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.894 ' HA ' HD13 ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.894 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.4 pp0? -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.492 ' O ' HD12 ' A' ' 68' ' ' LEU . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.717 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.054 HG23 HD11 ' A' ' 82' ' ' LEU . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.654 ' CG ' HG13 ' A' ' 103' ' ' VAL . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.054 HD11 HG23 ' A' ' 77' ' ' VAL . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 91' ' ' VAL . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.958 HG12 ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.562 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.667 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.958 ' HD2' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 25' ' ' ILE . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB2' HD11 ' A' ' 23' ' ' LEU . 3.9 tpt180 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 68' ' ' LEU . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 34' ' ' LEU . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.302 -0.319 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 27' ' ' LEU . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 74' ' ' LEU . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 90' ' ' VAL . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' ILE . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 HG11 ' A' ' 53' ' ' VAL . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' PRO . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 68' ' ' LEU . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.696 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.679 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.99 HG23 HD11 ' A' ' 82' ' ' LEU . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.541 ' ND2' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.485 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.99 HD11 HG23 ' A' ' 77' ' ' VAL . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' NZ ' HG11 ' A' ' 80' ' ' VAL . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.862 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.888 HG21 HG13 ' A' ' 51' ' ' ILE . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.921 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.921 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.679 HD23 ' HB ' ' A' ' 75' ' ' ILE . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.621 HD21 ' HD3' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD23 ' OD2' ' A' ' 65' ' ' ASP . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 N-CA-C 112.203 -0.359 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 27' ' ' LEU . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.834 HD11 HG22 ' A' ' 91' ' ' VAL . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.769 HG13 HG21 ' A' ' 90' ' ' VAL . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 56' ' ' ILE . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 39' ' ' THR . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.774 HD11 HG11 ' A' ' 53' ' ' VAL . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD2' HD23 ' A' ' 27' ' ' LEU . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB2' HG23 ' A' ' 25' ' ' ILE . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.037 HG23 HD11 ' A' ' 82' ' ' LEU . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.037 HD11 HG23 ' A' ' 77' ' ' VAL . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.836 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 87' ' ' GLN . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 77' ' ' VAL . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 68' ' ' LEU . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 105' ' ' LEU . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.55 HD22 ' HE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HE2' HD22 ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 56' ' ' ILE . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 HG11 ' A' ' 53' ' ' VAL . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.674 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' HG23 ' A' ' 25' ' ' ILE . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 68' ' ' LEU . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' CD ' ' A' ' 73' ' ' ARG . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.055 HG23 HD11 ' A' ' 82' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG12 ' HZ2' ' A' ' 85' ' ' LYS . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.055 HD11 HG23 ' A' ' 77' ' ' VAL . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.932 ' HE3' HD11 ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.859 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.932 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.825 ' HD2' HG12 ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' GLN . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.678 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' LEU . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 HD12 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.438 ' NH1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' ' 106' ' ' LEU . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.57 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.905 HD11 HG22 ' A' ' 91' ' ' VAL . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' HD1' ' A' ' 52' ' ' TYR . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 38' ' ' ILE . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.553 ' HD1' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 68' ' ' LEU . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.613 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 25' ' ' ILE . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.89 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 68' ' ' LEU . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 107' ' ' VAL . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.669 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.451 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 82' ' ' LEU . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.611 HG11 HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.983 HD22 HG13 ' A' ' 90' ' ' VAL . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.556 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.983 HG13 HD22 ' A' ' 82' ' ' LEU . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.905 HG22 HD11 ' A' ' 38' ' ' ILE . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 HG11 ' A' ' 80' ' ' VAL . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.922 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 26' ' ' GLN . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.585 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' ' 22' ' ' ARG . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 72' ' ' ASP . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' CE ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD21 ' CE ' ' A' ' 21' ' ' LYS . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 34' ' ' LEU . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HE2' HD13 ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.91 HD12 HG21 ' A' ' 51' ' ' ILE . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.91 HG21 HD12 ' A' ' 38' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 68' ' ' LEU . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 63' ' ' ILE . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 57' ' ' LEU . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.616 ' HB2' HG23 ' A' ' 25' ' ' ILE . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.729 ' C ' HD11 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 38' ' ' ILE . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 108' ' ' PHE . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.784 ' CG2' HD21 ' A' ' 82' ' ' LEU . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.784 HD21 ' CG2' ' A' ' 77' ' ' VAL . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.658 ' NZ ' HD23 ' A' ' 82' ' ' LEU . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.841 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 86' ' ' SER . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 86' ' ' SER . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HG3' HG12 ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.92 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.443 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.92 ' CG2' HG21 ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 25' ' ' ILE . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.64 ' HB2' HD11 ' A' ' 75' ' ' ILE . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.651 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.733 -0.147 . . . . 0.0 112.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 94' ' ' LEU . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.509 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 39' ' ' THR . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 56' ' ' ILE . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' ILE . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.895 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 68' ' ' LEU . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.935 HG23 HD23 ' A' ' 105' ' ' LEU . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.598 HD21 HG13 ' A' ' 103' ' ' VAL . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 90' ' ' VAL . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 82' ' ' LEU . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 77' ' ' VAL . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.614 HD13 HD12 ' A' ' 34' ' ' LEU . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.86 ' CD ' HG12 ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.087 HG21 HG22 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.481 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.087 HG22 HG21 ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.935 HD23 HG23 ' A' ' 77' ' ' VAL . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 75' ' ' ILE . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 25' ' ' ILE . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.723 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.516 -0.233 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 94' ' ' LEU . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 HG22 ' A' ' 91' ' ' VAL . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 38' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.781 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HB2' HG23 ' A' ' 25' ' ' ILE . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.898 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.72 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.039 HG23 HD11 ' A' ' 82' ' ' LEU . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 77' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' OD2' ' A' ' 81' ' ' ASP . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 86' ' ' SER . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 87' ' ' GLN . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 34' ' ' LEU . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HG3' HG12 ' A' ' 91' ' ' VAL . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.03 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 26' ' ' GLN . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.03 ' CG2' HG21 ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.72 HD23 ' HB ' ' A' ' 75' ' ' ILE . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 23' ' ' LEU . 4.6 tpp85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.566 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.162 0 N-CA-C 112.663 -0.175 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 27' ' ' LEU . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HE1' HD13 ' A' ' 34' ' ' LEU . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 51' ' ' ILE . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.79 HG13 HG21 ' A' ' 90' ' ' VAL . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG11 HD11 ' A' ' 56' ' ' ILE . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HG11 ' A' ' 53' ' ' VAL . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' TYR . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.892 HG23 HD21 ' A' ' 82' ' ' LEU . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 85' ' ' LYS . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.892 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 80' ' ' VAL . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 51' ' ' ILE . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.817 ' CD ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.93 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.93 ' CG2' HG21 ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.491 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.619 HG22 HD12 ' A' ' 25' ' ' ILE . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 23' ' ' LEU . 14.4 ptp180 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.74 ' CE ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.846 HD12 HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 91' ' ' VAL . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 68' ' ' LEU . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' CA ' HG22 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 63' ' ' ILE . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.926 ' HA ' HD13 ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.491 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.926 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' CB ' HG23 ' A' ' 25' ' ' ILE . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.894 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' LEU . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.626 ' HB ' HD23 ' A' ' 106' ' ' LEU . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.537 ' OD1' HG13 ' A' ' 103' ' ' VAL . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.019 HD11 HG23 ' A' ' 77' ' ' VAL . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.872 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 86' ' ' SER . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 38' ' ' ILE . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.974 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.974 HG22 HG21 ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD23 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.626 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 23' ' ' LEU . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.603 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.87 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.357 -0.297 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 94' ' ' LEU . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 91' ' ' VAL . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HA2' ' A' ' 84' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.487 HD12 ' OE1' ' A' ' 87' ' ' GLN . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 56' ' ' ILE . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.761 HD11 HG11 ' A' ' 53' ' ' VAL . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HA ' HD13 ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.495 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 25' ' ' ILE . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.87 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 68' ' ' LEU . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.847 ' HB3' HD12 ' A' ' 82' ' ' LEU . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 82' ' ' LEU . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 77' ' ' VAL . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' ' 85' ' ' LYS . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 77' ' ' VAL . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 48' ' ' SER . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 34' ' ' LEU . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HD3' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.909 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 23' ' ' LEU . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 25' ' ' ILE . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' HD11 ' A' ' 75' ' ' ILE . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.743 ' HD2' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.743 HD21 ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.681 HD12 ' CG2' ' A' ' 107' ' ' VAL . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.619 HD12 ' HE2' ' A' ' 36' ' ' PHE . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 34' ' ' LEU . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HE2' HD12 ' A' ' 27' ' ' LEU . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD11 HG22 ' A' ' 91' ' ' VAL . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 90' ' ' VAL . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 56' ' ' ILE . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.69 ' HA ' HD13 ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 25' ' ' ILE . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG12 ' HZ3' ' A' ' 85' ' ' LYS . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.909 ' HE3' HD11 ' A' ' 93' ' ' LEU . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 86' ' ' SER . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.842 HG12 ' HG3' ' A' ' 95' ' ' ARG . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.909 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 94' ' ' LEU . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.842 ' HG3' HG12 ' A' ' 91' ' ' VAL . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.789 HG21 HG22 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 26' ' ' GLN . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 75' ' ' ILE . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.681 ' CG2' HD12 ' A' ' 25' ' ' ILE . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.811 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.811 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.695 HD12 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.7 HD13 ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 51' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 38' ' ' ILE . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 56' ' ' ILE . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.795 HD11 HG11 ' A' ' 53' ' ' VAL . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.642 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD2' HD23 ' A' ' 27' ' ' LEU . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.657 ' HB2' HG23 ' A' ' 25' ' ' ILE . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.9 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 68' ' ' LEU . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 38' ' ' ILE . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.665 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HD11 ' A' ' 82' ' ' LEU . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG11 ' HE3' ' A' ' 85' ' ' LYS . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 77' ' ' VAL . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HE3' HG11 ' A' ' 80' ' ' VAL . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 86' ' ' SER . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.551 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.683 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.054 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.054 HG22 HG21 ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.695 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 75' ' ' ILE . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 68' ' ' LEU . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.601 -0.2 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HE1' ' A' ' 36' ' ' PHE . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 72' ' ' ASP . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 53' ' ' VAL . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.717 ' HB2' HG23 ' A' ' 25' ' ' ILE . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 22' ' ' ARG . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.997 HG23 HD11 ' A' ' 82' ' ' LEU . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.563 HD22 HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.997 HD11 HG23 ' A' ' 77' ' ' VAL . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.823 HG22 HD22 ' A' ' 82' ' ' LEU . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.641 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.055 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.055 HG22 HG21 ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.565 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.568 ' HD2' HD21 ' A' ' 106' ' ' LEU . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD23 ' A' ' 34' ' ' LEU . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.384 -0.287 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 HD13 ' HE1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.845 HG21 ' CD1' ' A' ' 74' ' ' LEU . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' CG2' HD13 ' A' ' 38' ' ' ILE . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 68' ' ' LEU . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.412 HD11 HG11 ' A' ' 53' ' ' VAL . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HA ' HD13 ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB2' HG23 ' A' ' 25' ' ' ILE . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' N ' HD12 ' A' ' 68' ' ' LEU . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.845 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 82' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 77' ' ' VAL . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 93' ' ' LEU . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.85 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.582 HD11 ' NZ ' ' A' ' 85' ' ' LYS . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.032 HG21 HG22 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 77' ' ' VAL . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HD2' ' A' ' 22' ' ' ARG . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 25' ' ' ILE . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.462 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 106' ' ' LEU . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 68' ' ' LEU . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.421 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 34' ' ' LEU . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 N-CA-C 112.406 -0.278 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 27' ' ' LEU . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.844 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.786 HG13 HG21 ' A' ' 90' ' ' VAL . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 56' ' ' ILE . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.578 HD11 HG11 ' A' ' 53' ' ' VAL . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.805 ' HA ' HD13 ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.805 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.666 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 82' ' ' LEU . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 85' ' ' LYS . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.855 HD11 HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' CE ' HG11 ' A' ' 80' ' ' VAL . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.827 HG22 HD22 ' A' ' 82' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.659 HD21 ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 94' ' ' LEU . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.968 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.432 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.968 ' CG2' HG21 ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.421 ' CG2' HD12 ' A' ' 23' ' ' LEU . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' HB2' HD11 ' A' ' 75' ' ' ILE . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 27' ' ' LEU . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HE1' HD22 ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.939 HD12 HG21 ' A' ' 51' ' ' ILE . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.939 HG21 HD12 ' A' ' 38' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 56' ' ' ILE . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.706 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 25' ' ' ILE . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.91 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' HD12 ' A' ' 68' ' ' LEU . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.648 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 76' ' ' GLU . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 75' ' ' ILE . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.807 HG23 HD11 ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 HG22 ' A' ' 90' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.849 HG22 HD22 ' A' ' 82' ' ' LEU . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.82 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.951 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.951 ' CG2' HG21 ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.559 HD23 HG13 ' A' ' 77' ' ' VAL . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.648 HG21 ' OD2' ' A' ' 72' ' ' ASP . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' NZ ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.614 HD13 ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.614 ' CE2' HD13 ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 74' ' ' LEU . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 90' ' ' VAL . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 56' ' ' ILE . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD11 HG11 ' A' ' 53' ' ' VAL . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.857 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.586 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG13 ' A' ' 103' ' ' VAL . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.4 ' CG1' ' HE2' ' A' ' 85' ' ' LYS . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 77' ' ' VAL . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 86' ' ' SER . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.027 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 26' ' ' GLN . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.672 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 25' ' ' ILE . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.814 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.5 tpt180 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.707 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' CD ' ' A' ' 21' ' ' LYS . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.666 HD12 ' HE1' ' A' ' 36' ' ' PHE . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 91' ' ' VAL . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.934 HG11 HD11 ' A' ' 56' ' ' ILE . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CA ' HG22 ' A' ' 39' ' ' THR . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.934 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HA ' HD13 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.668 ' HB2' HG23 ' A' ' 25' ' ' ILE . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.513 ' O ' HD12 ' A' ' 68' ' ' LEU . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 75' ' ' ILE . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.016 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.016 HG22 HG21 ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 75' ' ' ILE . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.7 mttp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.718 0.294 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -97.44 120.42 37.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 20' ' ' GLY . 2.1 p -83.9 159.8 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 111.069 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 141.27 -168.95 25.24 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.466 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.768 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.52 150.22 30.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.348 . . . . 0.0 110.808 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -91.99 146.45 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.289 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.768 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -134.44 156.13 49.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.207 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.31 120.82 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.066 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.93 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mt -130.09 119.94 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.913 0.387 . . . . 0.0 111.751 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.48 123.09 47.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.197 179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.684 HD12 HD23 ' A' ' 34' ' ' LEU . 14.3 mt -111.93 135.55 52.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.67 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -83.3 110.36 18.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.611 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -49.79 135.41 19.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.094 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' C ' HG23 ' A' ' 31' ' ' THR . . . -139.03 46.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.87 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 30' ' ' GLY . 1.6 p 69.59 -58.99 0.51 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -76.06 55.95 0.97 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 45.82 -142.32 4.53 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.973 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.684 HD23 HD12 ' A' ' 27' ' ' LEU . 4.7 mp -120.43 -9.18 9.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.566 0.222 . . . . 0.0 111.42 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 78.65 37.16 27.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.974 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -145.72 130.42 18.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.973 0.416 . . . . 0.0 111.345 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.52 134.69 49.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.901 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.717 HD12 HG21 ' A' ' 51' ' ' ILE . 23.5 pt -112.06 139.81 34.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.392 0.615 . . . . 0.0 112.443 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.77 163.95 11.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.23 178.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.7 t -120.23 130.8 54.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.221 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -59.7 -28.29 67.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.797 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.3 48.75 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 46.5 t -64.79 -47.84 86.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.37 169.09 18.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.95 -55.22 17.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.413 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.13 73.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.9 -0.666 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.16 -69.5 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.3 m -163.05 109.38 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.874 0.369 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.98 128.52 19.69 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 43' ' ' VAL . 37.8 Cg_endo -67.43 134.46 33.35 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.371 2.047 . . . . 0.0 112.828 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.717 HG21 HD12 ' A' ' 38' ' ' ILE . 1.4 mm -111.59 137.53 43.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.529 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 0.8 OUTLIER -145.04 144.6 31.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.064 0.459 . . . . 0.0 111.309 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 56' ' ' ILE . 18.6 t -54.05 105.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 9.6 ptpp? -64.84 -31.32 72.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.99 145.45 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.69 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.9 mm -93.35 112.13 25.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.29 152.16 96.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.098 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.643 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.0 Cg_endo -83.49 24.24 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.964 2.443 . . . . 0.0 113.607 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -149.39 87.93 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.731 0.301 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.512 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.46 179.17 48.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.83 -26.62 57.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.62 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.37 -55.52 15.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.609 0.242 . . . . 0.0 111.265 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.643 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.3 tt -63.21 -36.55 76.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.444 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 5.4 pt20 -71.35 -36.19 71.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.373 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.36 -34.2 70.25 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.816 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.93 57.12 12.8 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.352 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -134.29 -45.66 0.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.828 0.347 . . . . 0.0 111.234 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.06 120.16 41.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.827 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttp -106.39 -169.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.98 169.33 16.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.185 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.4 20.5 74.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.686 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -113.8 155.57 25.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.809 0.338 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 8.4 ttt-85 -117.47 129.45 55.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.73 HD23 ' CG2' ' A' ' 77' ' ' VAL . 2.6 mp -71.63 110.94 6.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.502 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.781 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -89.54 -28.27 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.677 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.97 143.61 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.994 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.013 HG23 HD11 ' A' ' 82' ' ' LEU . 53.9 t -131.24 128.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.2 31.38 11.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.5 19.54 71.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.652 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -108.11 147.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.166 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.39 110.84 22.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.36 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.013 HD11 HG23 ' A' ' 77' ' ' VAL . 2.1 mt -88.97 23.61 2.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.064 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.84 62.76 2.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.978 0.418 . . . . 0.0 110.892 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.52 -20.08 1.17 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.48 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HE2' HD22 ' A' ' 93' ' ' LEU . 2.4 mtpp -55.95 -93.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.873 -0.193 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.75 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.5 t 159.85 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.3 tp-100 -68.47 -54.2 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.02 0.438 . . . . 0.0 109.988 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.5 -30.66 71.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.596 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 9.1 mm-40 -68.87 -49.43 58.38 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.854 ' HA ' HD23 ' A' ' 93' ' ' LEU . 54.7 t -60.44 -55.17 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.103 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.7 t -58.47 -30.9 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.551 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 t -67.08 -43.68 82.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -64.74 -35.55 81.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.831 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.721 HD23 ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -77.97 -40.54 38.95 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HE ' HG12 ' A' ' 91' ' ' VAL . 15.5 mtm180 -62.15 -30.53 71.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.545 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 t -69.6 -32.67 71.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -57.67 140.24 51.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.494 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 176.24 5.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.96 157.92 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.599 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 59.06 58.53 3.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.121 0.486 . . . . 0.0 110.336 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.02 100.04 0.17 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.835 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 26' ' ' GLN . 1.3 m -70.45 111.04 5.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.034 0.445 . . . . 0.0 110.801 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 88.0 t -94.46 113.05 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.814 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.38 106.39 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.436 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.5 mp -109.02 109.81 20.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.592 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.781 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.1 tp -80.18 112.06 17.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.75 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.541 HG22 HD12 ' A' ' 25' ' ' ILE . 18.0 m -104.43 174.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.925 0.393 . . . . 0.0 111.678 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 56.3 t80 -135.76 111.02 9.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.767 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HE ' HD11 ' A' ' 23' ' ' LEU . 26.4 ttm-85 -87.14 141.66 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -130.01 129.25 43.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.833 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -83.12 169.29 16.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -111.6 36.85 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 107.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.809 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 20' ' ' GLY . 15.7 t -126.65 160.18 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 129.89 169.28 12.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.492 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.8 141.55 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.81 0.338 . . . . 0.0 110.763 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -94.8 139.11 31.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.201 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -128.69 143.79 51.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.964 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -91.36 124.91 35.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.32 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.534 HD12 ' CG2' ' A' ' 107' ' ' VAL . 23.7 mt -130.81 114.74 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.58 124.65 49.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.235 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.695 ' HB2' HD23 ' A' ' 34' ' ' LEU . 16.8 mt -111.94 141.35 45.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.696 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -82.36 121.23 26.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.676 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 137.45 57.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.011 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.98 -137.25 2.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.346 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.3 p -87.35 148.02 25.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.357 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 59.42 30.99 20.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 71.08 -119.7 8.15 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.329 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD13 ' HE1' ' A' ' 36' ' ' PHE . 1.8 mp -123.65 -1.59 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.532 0.206 . . . . 0.0 111.495 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 74.49 42.57 33.09 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.89 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.739 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.86 128.95 11.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.34 134.89 48.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.801 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' A' ' 51' ' ' ILE . 18.2 pt -108.04 139.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.311 0.577 . . . . 0.0 112.068 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -103.55 168.78 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.127 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.3 p -129.06 132.76 47.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.871 0.367 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -57.46 -21.72 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.13 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.19 47.6 3.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.887 0.375 . . . . 0.0 110.83 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 41' ' ' ARG . 48.1 t -80.25 -69.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.31 154.65 19.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.994 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.66 -28.73 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.76 50.6 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.293 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.45 -42.38 0.21 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.545 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -160.18 110.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.024 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.7 124.83 4.49 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 36.9 Cg_endo -66.6 137.39 46.03 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.273 1.982 . . . . 0.0 112.451 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.717 HG13 HG21 ' A' ' 90' ' ' VAL . 3.0 mm -105.23 135.39 43.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.526 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.4 m-85 -124.22 174.37 7.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.694 HG11 HD11 ' A' ' 56' ' ' ILE . 39.1 t -89.35 98.8 8.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.945 0.402 . . . . 0.0 110.598 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.473 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 2.2 tptm -63.81 -31.42 72.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -175.06 161.58 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.694 HD11 HG11 ' A' ' 53' ' ' VAL . 35.6 mm -122.79 102.87 12.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.128 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.7 mt -65.14 143.07 98.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.341 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.894 ' HA ' HD13 ' A' ' 63' ' ' ILE . 68.2 Cg_endo -73.49 -2.34 12.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.777 2.318 . . . . 0.0 113.415 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -124.0 75.03 1.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 111.061 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -162.87 176.73 39.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.65 -26.59 57.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.37 -55.13 11.28 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.894 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.9 tt -64.73 -36.54 77.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.4 pp0? -71.99 -34.36 68.85 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.701 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -71.85 -38.67 70.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.888 0.375 . . . . 0.0 110.784 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.57 61.31 3.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -138.13 -59.96 0.63 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.953 0.406 . . . . 0.0 111.132 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -97.44 121.31 39.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.492 ' O ' HD12 ' A' ' 68' ' ' LEU . 18.3 mttt -110.16 -169.07 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.005 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 156.39 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.67 -2.49 88.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.871 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.59 151.44 39.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.777 0.322 . . . . 0.0 110.77 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HG2' ' CE1' ' A' ' 52' ' ' TYR . 1.9 mtt85 -106.03 103.67 13.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 0.9 OUTLIER -61.87 114.86 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.193 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.717 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.4 mt -98.66 -28.87 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.948 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -158.34 157.06 31.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.088 0.47 . . . . 0.0 111.61 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.054 HG23 HD11 ' A' ' 82' ' ' LEU . 61.7 t -139.5 125.2 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.52 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.654 ' CG ' HG13 ' A' ' 103' ' ' VAL . 28.1 m120 53.28 30.17 9.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.954 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.04 18.1 68.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.842 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.6 t -108.35 138.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.972 0.415 . . . . 0.0 111.303 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.31 117.55 16.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.296 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.054 HD11 HG23 ' A' ' 77' ' ' VAL . 69.9 mt -86.62 18.03 3.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.386 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.62 84.9 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.617 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.76 31.65 1.2 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.056 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.89 -112.87 0.34 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER 178.9 165.89 0.9 Allowed 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.764 0.316 . . . . 0.0 110.505 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.844 ' O ' HG23 ' A' ' 91' ' ' VAL . 9.5 tt0 -68.52 -54.41 16.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.927 0.394 . . . . 0.0 109.955 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.47 -30.4 71.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.58 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.433 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -69.84 -49.45 52.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.74 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -62.5 -49.32 84.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.324 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.958 HG12 ' HD2' ' A' ' 95' ' ' ARG . 39.3 t -60.04 -32.55 50.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.833 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -64.46 -38.32 90.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.189 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.562 HD21 ' NZ ' ' A' ' 85' ' ' LYS . 6.1 mt -59.56 -51.84 68.1 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 109.845 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.667 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -64.24 -46.24 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.691 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.958 ' HD2' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -60.56 -30.72 69.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.49 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -69.55 -29.83 67.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.383 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.988 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -64.97 139.4 58.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.77 169.02 9.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.35 153.61 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.553 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 59.6 76.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.992 0.425 . . . . 0.0 110.204 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.11 105.07 0.19 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.716 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.95 111.74 6.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.913 0.387 . . . . 0.0 111.297 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.988 ' CG2' HG21 ' A' ' 97' ' ' THR . 57.3 t -94.85 117.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.487 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -88.09 107.56 18.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.838 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 77' ' ' VAL . 1.2 mp -112.62 112.48 24.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -80.98 111.9 17.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.141 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 25' ' ' ILE . 21.7 m -104.98 170.41 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 62.5 t80 -127.21 114.89 18.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HB2' HD11 ' A' ' 23' ' ' LEU . 3.9 tpt180 -106.23 127.18 53.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.049 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.25 134.22 36.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.93 -178.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.14 41.64 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.783 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.035 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 120.827 0.346 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -108.1 92.59 4.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.843 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.1 t -127.78 7.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 111.654 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.63 -172.68 32.02 Favored Glycine 0 C--N 1.316 -0.55 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.59 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.1 153.44 32.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 26.0 ptt180 -106.47 138.67 42.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 155.23 50.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.184 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -98.2 119.59 37.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 68' ' ' LEU . 29.7 mt -126.21 114.79 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -102.37 155.05 18.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.74 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 34' ' ' LEU . 19.6 mt -141.07 128.15 20.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 111.819 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.1 tptm -78.63 120.05 22.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.114 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 144.72 47.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.05 45.46 0.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.902 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.723 HG23 ' HB3' ' A' ' 99' ' ' MET . 0.5 OUTLIER 47.3 29.18 1.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -152.87 43.3 0.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.47 -155.9 22.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.302 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 27' ' ' LEU . 6.6 mp -121.22 -8.87 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.491 0.186 . . . . 0.0 111.429 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 75.63 29.61 59.33 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.907 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -145.75 128.2 15.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.992 0.425 . . . . 0.0 111.283 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.39 134.71 49.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.809 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 74' ' ' LEU . 20.1 pt -109.36 140.5 27.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.241 0.544 . . . . 0.0 112.111 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.49 171.08 8.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.138 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 p -133.85 126.39 30.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 111.129 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.29 -32.97 74.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.75 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.32 55.63 2.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.679 HG23 ' HD2' ' A' ' 50' ' ' PRO . 55.4 t -56.21 -50.25 71.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 165.7 28.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.272 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.08 -39.19 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.154 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.48 -34.71 76.64 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.87 -143.5 14.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m 59.56 21.87 10.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.093 0.473 . . . . 0.0 111.206 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.1 140.78 32.68 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.679 ' HD2' HG23 ' A' ' 43' ' ' VAL . 58.8 Cg_endo -72.59 144.72 40.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.531 2.154 . . . . 0.0 112.672 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 90' ' ' VAL . 1.5 mm -111.1 149.83 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 3.3 m-85 -141.37 174.05 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' ILE . 39.5 t -95.36 98.65 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 110.662 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -58.65 -33.17 69.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.082 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.02 149.4 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.989 0.423 . . . . 0.0 111.95 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.527 HD11 HG11 ' A' ' 53' ' ' VAL . 40.8 mm -94.33 106.18 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.461 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.55 154.81 22.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 85.6 Cg_endo -82.98 16.81 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 113.842 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 58' ' ' PRO . 6.3 mmm180 -147.66 88.35 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 111.273 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.43 -179.5 47.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.798 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.66 -34.35 60.47 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -58.91 -55.14 38.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.497 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 58' ' ' PRO . 5.5 tt -58.53 -41.77 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 21.0 pt20 -71.33 -34.41 70.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.882 0.372 . . . . 0.0 110.562 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -34.09 70.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.741 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.1 58.59 12.86 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.46 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -133.51 -45.79 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.183 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' HB2' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -108.69 121.68 45.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.822 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' O ' HD12 ' A' ' 68' ' ' LEU . 28.3 mttt -108.92 -169.93 1.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.44 165.84 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.061 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 17.18 80.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.489 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.95 146.88 27.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -99.2 129.22 45.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.696 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -78.74 107.79 11.7 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.58 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.679 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.7 mt -92.5 -28.68 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.476 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -163.73 148.29 10.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 111.802 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.99 HG23 HD11 ' A' ' 82' ' ' LEU . 84.5 t -136.93 125.12 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.541 ' ND2' HG13 ' A' ' 103' ' ' VAL . 0.6 OUTLIER 57.44 30.32 18.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.562 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.46 18.36 76.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.681 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.485 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 94.0 t -108.43 149.48 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 111.338 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.05 115.24 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.36 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.99 HD11 HG23 ' A' ' 77' ' ' VAL . 5.9 mt -87.52 21.04 2.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.77 36.88 1.34 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.935 0.398 . . . . 0.0 110.974 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.47 39.23 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.115 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' NZ ' HG11 ' A' ' 80' ' ' VAL . 34.9 mttt -125.69 -112.74 0.29 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.376 0.131 . . . . 0.0 110.871 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.1 m 174.92 177.32 0.15 Allowed 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.422 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.862 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.0 tt0 -68.53 -54.66 15.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.15 -30.53 71.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.681 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.3 mm-40 -71.09 -51.02 27.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.828 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.888 HG21 HG13 ' A' ' 51' ' ' ILE . 76.0 t -60.99 -44.98 99.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.459 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 87' ' ' GLN . 51.5 t -61.53 -32.81 54.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.869 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 t -65.01 -37.73 88.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.196 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -61.02 -52.08 66.49 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.914 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -64.34 -44.42 91.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.761 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -61.42 -30.77 70.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.488 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -42.42 96.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.921 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -58.31 129.05 40.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.492 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.96 -176.55 3.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.723 ' HB3' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -52.72 142.81 17.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.577 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 60.1 75.23 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.04 0.448 . . . . 0.0 110.072 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.32 104.83 0.21 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.683 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.422 ' CG2' ' HB2' ' A' ' 26' ' ' GLN . 86.4 m -70.57 111.85 6.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.921 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.41 112.24 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.407 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 58.6 m -84.63 113.29 21.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.885 0.374 . . . . 0.0 110.819 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.51 111.17 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.679 HD23 ' HB ' ' A' ' 75' ' ' ILE . 7.6 tp -77.94 111.78 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.956 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.26 171.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.938 0.399 . . . . 0.0 111.535 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 12.3 t80 -131.22 115.98 17.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.586 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -99.0 132.78 44.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.054 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -92.56 136.87 32.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.97 153.27 38.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.79 30.28 19.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.116 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.1 tptt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.81 0.338 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -167.9 65.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 20' ' ' GLY . 18.2 t -142.2 160.03 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.989 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 132.46 127.87 2.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.654 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.621 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.87 159.28 37.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.618 0.247 . . . . 0.0 110.564 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 mtt180 -106.01 148.75 27.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.968 0.413 . . . . 0.0 111.261 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.621 HD21 ' HD3' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -133.48 150.05 51.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.915 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -109.77 131.42 55.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.143 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -138.31 121.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.02 0.438 . . . . 0.0 111.853 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.02 118.68 37.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.882 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD23 ' OD2' ' A' ' 65' ' ' ASP . 14.0 mt -111.7 130.71 55.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.113 0.482 . . . . 0.0 111.851 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -85.47 118.18 24.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.73 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -51.5 119.86 4.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.56 -88.33 2.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.575 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.44 -48.04 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -85.01 57.48 4.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.75 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.68 -113.69 5.22 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.203 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 27' ' ' LEU . 3.0 mt -140.14 13.89 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.805 0.336 . . . . 0.0 111.471 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 52.3 23.14 11.92 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -139.96 130.34 25.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.107 0.48 . . . . 0.0 111.559 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.1 t -106.88 135.06 49.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.857 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.834 HD11 HG22 ' A' ' 91' ' ' VAL . 26.5 pt -109.18 140.43 27.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.43 0.633 . . . . 0.0 112.293 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -113.73 171.14 7.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.108 178.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 t -126.82 133.46 50.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.095 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -59.0 -25.02 63.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 63.83 52.14 2.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 HG23 ' HD2' ' A' ' 50' ' ' PRO . 47.4 t -77.82 -68.85 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.53 151.9 24.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.94 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.99 -42.1 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.956 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.29 32.56 0.14 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.543 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.69 -62.17 0.83 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.475 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.54 104.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.886 0.374 . . . . 0.0 110.984 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.88 25.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 43' ' ' VAL . 55.5 Cg_endo -69.96 128.55 16.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.408 2.072 . . . . 0.0 112.614 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.769 HG13 HG21 ' A' ' 90' ' ' VAL . 6.9 mm -90.72 151.1 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 25.4 m-85 -140.46 174.6 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.774 HG11 HD11 ' A' ' 56' ' ' ILE . 12.3 t -90.36 98.72 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.769 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 39' ' ' THR . 44.8 tttm -57.28 -32.67 66.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.045 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -179.43 156.54 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.677 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.774 HD11 HG11 ' A' ' 53' ' ' VAL . 33.4 mm -112.14 94.42 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.475 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.55 154.23 6.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.386 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HA ' HD13 ' A' ' 63' ' ' ILE . 94.5 Cg_endo -84.27 19.3 1.39 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.969 2.446 . . . . 0.0 113.471 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.43 86.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.833 0.349 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -178.29 -178.16 47.51 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.765 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . -76.08 -24.55 55.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -68.42 -55.47 11.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.428 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -63.64 -35.57 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-O 120.642 0.258 . . . . 0.0 111.572 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.2 pt20 -71.38 -37.52 71.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 110.351 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD2' HD23 ' A' ' 27' ' ' LEU . 20.1 m-20 -71.62 -33.76 69.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.759 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.92 41.1 98.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.181 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB2' HG23 ' A' ' 25' ' ' ILE . 79.1 mtt180 -116.6 -58.4 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.796 0.331 . . . . 0.0 111.24 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.879 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.74 120.01 37.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.747 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.5 mmtt -107.53 -171.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.028 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.24 167.12 19.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.172 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.52 18.45 77.08 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.677 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.63 166.91 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 36.0 ttp180 -119.97 119.07 32.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HB3' HD13 ' A' ' 82' ' ' LEU . 3.3 mp -71.26 107.81 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.54 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.0 mt -79.95 -29.9 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 2.0 pt-20 -173.25 157.81 3.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.119 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.037 HG23 HD11 ' A' ' 82' ' ' LEU . 85.0 t -126.62 131.46 71.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.504 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.6 28.08 5.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.91 14.51 64.71 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.702 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.9 t -108.15 116.74 52.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.418 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 14.2 p30 -62.45 114.75 3.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.154 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.037 HD11 HG23 ' A' ' 77' ' ' VAL . 1.3 mt -84.26 21.78 1.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.08 96.62 10.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.39 15.42 17.52 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.531 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.1 mttt -92.48 -91.67 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.43 0.157 . . . . 0.0 110.818 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.796 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 162.76 162.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 110.262 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.836 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.2 tp60 -68.43 -54.01 19.88 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -30.43 71.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.58 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 8.7 mm-40 -70.5 -50.82 33.81 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.536 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 86' ' ' SER . 69.2 t -59.8 -47.83 89.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.207 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 87' ' ' GLN . 41.1 t -61.49 -32.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.06 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -65.43 -34.99 79.58 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.262 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.04 -51.75 65.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 109.758 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -66.3 -41.3 89.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.035 179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -30.48 70.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.599 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.6 t -68.97 -31.17 69.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.68 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -55.65 139.64 43.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 163.43 13.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.4 mmt -45.86 147.15 1.02 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 60.83 84.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.894 0.378 . . . . 0.0 110.328 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.06 107.06 0.22 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.905 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.58 107.82 4.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.928 ' CG2' HG21 ' A' ' 97' ' ' THR . 86.2 t -94.84 112.6 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.648 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.96 107.82 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 77' ' ' VAL . 1.3 mp -110.55 123.35 49.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 tp -86.9 126.29 34.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.948 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 25' ' ' ILE . 23.4 m -117.38 168.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.86 0.362 . . . . 0.0 111.192 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.9 t80 -138.95 120.9 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.542 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -100.83 110.92 23.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 131.38 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.072 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 63.74 133.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.82 -33.57 12.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.17 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -132.44 141.88 49.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 20' ' ' GLY . 2.1 p -80.51 159.63 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 163.83 -139.26 5.76 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.644 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -174.69 170.84 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.712 0.291 . . . . 0.0 110.771 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -120.85 145.59 47.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.192 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -134.07 156.11 48.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.104 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.6 123.94 47.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.161 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 68' ' ' LEU . 8.8 mt -127.64 127.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.978 0.418 . . . . 0.0 111.903 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.4 mp0 -107.54 124.17 49.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.987 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.678 HD12 ' CD1' ' A' ' 105' ' ' LEU . 66.8 mt -112.26 125.03 53.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.207 0.527 . . . . 0.0 111.905 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -78.99 115.83 18.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.516 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -52.12 130.76 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -118.93 -117.45 2.71 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.02 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -84.75 57.52 4.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.731 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.87 -114.67 6.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.55 HD22 ' HE2' ' A' ' 36' ' ' PHE . 4.8 mp -140.72 15.74 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 55.92 27.16 50.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.525 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HE2' HD22 ' A' ' 34' ' ' LEU . 3.7 p90 -144.2 127.74 17.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.055 0.427 . . . . 0.0 111.387 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -107.78 134.71 50.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.049 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.656 HD12 HG21 ' A' ' 51' ' ' ILE . 22.9 pt -113.89 139.87 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.354 0.597 . . . . 0.0 112.074 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -102.32 167.1 10.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.334 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 p -119.58 124.16 45.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.19 -35.61 80.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 59.65 70.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.456 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 46.4 t -69.98 -49.18 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.636 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 162.41 36.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.288 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 mm -60.8 -37.4 76.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.811 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.26 56.62 4.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.564 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.02 -140.44 31.37 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 59.85 21.47 10.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.13 126.62 37.42 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.836 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 43' ' ' VAL . 57.3 Cg_endo -71.79 149.66 54.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.608 2.205 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.656 HG21 HD12 ' A' ' 38' ' ' ILE . 2.3 mm -108.57 151.04 10.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.122 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 16.1 m-85 -147.28 132.84 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.874 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 56' ' ' ILE . 27.8 t -59.85 101.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.867 0.365 . . . . 0.0 110.809 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -63.1 -29.97 71.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.148 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -173.61 152.53 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.223 0.535 . . . . 0.0 111.95 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 HG11 ' A' ' 53' ' ' VAL . 37.8 mm -110.02 99.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.314 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.57 151.2 41.47 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.674 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.9 Cg_endo -83.24 27.14 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.94 2.427 . . . . 0.0 113.51 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -152.38 82.93 1.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.652 0.263 . . . . 0.0 110.801 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.76 -177.96 45.2 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.885 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.04 -28.6 57.73 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.635 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -66.33 -55.35 16.38 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.371 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -63.49 -36.03 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.442 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 61' ' ' ALA . 7.2 pt20 -71.54 -36.85 71.13 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.553 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.65 -33.95 69.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 60.86 6.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.282 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' HG23 ' A' ' 25' ' ' ILE . 7.6 mtp180 -138.4 -46.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 111.171 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -109.31 120.72 43.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.795 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' O ' HD12 ' A' ' 68' ' ' LEU . 4.2 mmtt -104.55 -172.17 2.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.21 154.26 23.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.162 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.46 -15.36 60.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.629 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.46 162.19 21.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.35 . . . . 0.0 110.872 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -114.5 126.57 55.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.61 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -77.01 116.05 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.919 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' CD ' ' A' ' 73' ' ' ARG . 3.7 mt -101.97 -28.41 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.167 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 19.8 mt-10 -158.39 145.71 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.053 0.454 . . . . 0.0 111.692 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.055 HG23 HD11 ' A' ' 82' ' ' LEU . 73.0 t -136.83 122.45 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.316 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m120 62.47 29.52 17.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.678 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.75 11.74 84.33 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.931 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG12 ' HZ2' ' A' ' 85' ' ' LYS . 36.6 t -108.69 140.74 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 111.468 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.65 117.96 19.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.055 HD11 HG23 ' A' ' 77' ' ' VAL . 1.2 mt -84.63 19.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.091 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.92 67.15 4.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.979 0.419 . . . . 0.0 110.625 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.18 42.47 0.12 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.048 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.932 ' HE3' HD11 ' A' ' 93' ' ' LEU . 11.5 mtmm -126.61 -97.84 0.41 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.994 -0.121 . . . . 0.0 111.006 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.809 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.8 t 166.56 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.75 0.31 . . . . 0.0 110.541 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.859 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.74 -54.58 15.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 0.0 109.985 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -62.12 -30.22 70.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.734 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 63.3 mt-10 -70.94 -53.88 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.547 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 86' ' ' SER . 82.0 t -57.42 -46.2 85.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.421 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.2 t -64.39 -32.2 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.845 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -34.66 78.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.932 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.2 mt -67.7 -52.62 35.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.197 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -66.77 -30.21 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.685 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.825 ' HD2' HG12 ' A' ' 91' ' ' VAL . 10.7 mtt85 -72.43 -31.04 65.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.991 0.424 . . . . 0.0 110.272 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -44.82 87.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.928 HG21 HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -48.0 123.75 6.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.528 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -89.78 179.7 5.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.049 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 25.7 mmt -49.98 138.54 15.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.608 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 60.7 90.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.438 . . . . 0.0 110.159 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.18 107.5 0.21 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.647 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' GLN . 20.1 m -71.04 115.45 10.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.032 0.444 . . . . 0.0 111.415 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.928 HG22 HG21 ' A' ' 97' ' ' THR . 3.9 t -94.39 125.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.064 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -84.45 129.75 34.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.678 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -135.85 108.91 7.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' LEU . 20.2 tp -83.4 110.68 18.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.811 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 HG22 HD12 ' A' ' 25' ' ' ILE . 11.2 m -105.64 172.26 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.498 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 15.1 t80 -134.08 121.22 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.618 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' NH1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -104.22 140.5 37.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.7 149.46 23.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.774 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.4 173.43 12.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -98.39 35.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -131.91 167.18 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.4 t -108.72 6.93 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.21 0.528 . . . . 0.0 111.477 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.29 148.8 20.17 Favored Glycine 0 C--N 1.316 -0.556 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.328 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' CD ' ' N ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -145.19 -177.44 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.957 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.606 ' HD3' HD11 ' A' ' 106' ' ' LEU . 11.3 ttm180 -120.9 146.05 47.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.946 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 148.1 36.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.017 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -104.95 140.1 38.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.225 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.89 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.02 131.51 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.035 0.445 . . . . 0.0 111.797 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.57 ' HB3' HG22 ' A' ' 102' ' ' THR . 1.2 mp0 -110.58 118.08 35.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.94 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 62' ' ' ALA . 16.7 mt -111.87 120.08 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.147 0.499 . . . . 0.0 112.055 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -70.8 105.59 3.27 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.576 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -56.44 117.59 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.97 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.31 -81.08 0.27 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.506 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -136.98 156.61 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.344 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.82 50.46 10.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.07 -103.88 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.499 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -128.23 -37.48 1.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.99 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 116.23 14.79 7.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.838 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -150.38 141.13 22.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.944 0.402 . . . . 0.0 111.37 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.77 134.71 49.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.793 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.905 HD11 HG22 ' A' ' 91' ' ' VAL . 23.0 pt -102.15 140.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.399 0.619 . . . . 0.0 112.068 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' HD1' ' A' ' 52' ' ' TYR . 1.1 t -101.54 171.32 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.238 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.1 t -144.34 129.13 18.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.121 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -60.19 -25.07 65.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.759 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 62.91 65.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' HD2' ' A' ' 50' ' ' PRO . 39.5 t -76.16 -45.8 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.85 166.74 23.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.93 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.59 -67.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.301 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.62 59.66 0.68 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.525 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.98 -105.33 1.36 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.55 104.94 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.1 138.72 24.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.962 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.636 ' HD2' HG23 ' A' ' 43' ' ' VAL . 57.8 Cg_endo -71.27 120.93 7.34 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.468 2.112 . . . . 0.0 112.717 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 38' ' ' ILE . 2.8 mm -106.56 141.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.034 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.553 ' HD1' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.67 174.25 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.626 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 68' ' ' LEU . 39.9 t -86.22 98.99 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.802 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 15.9 tttt -56.09 -31.0 62.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.233 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -175.98 152.17 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.019 0.438 . . . . 0.0 111.9 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' CD1' HG11 ' A' ' 53' ' ' VAL . 32.1 mm -105.33 103.83 15.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.464 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.3 mt -61.66 151.79 77.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.329 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 63' ' ' ILE . 89.6 Cg_endo -84.48 29.52 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.995 2.463 . . . . 0.0 113.382 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -156.74 81.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.024 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -177.35 163.05 31.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.694 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.95 -33.67 62.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.613 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -59.75 -55.66 31.57 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -63.85 -33.04 59.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 111.266 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -70.94 -40.22 72.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.057 0.456 . . . . 0.0 109.993 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -71.08 -33.76 70.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.676 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.62 42.4 99.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.086 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' HB2' HG23 ' A' ' 25' ' ' ILE . 1.3 mtt180 -116.15 -49.44 2.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.86 0.362 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.89 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.55 119.77 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.795 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 68' ' ' LEU . 13.9 mttm -105.83 -170.01 1.67 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.029 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.92 172.85 12.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.56 26.23 64.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD2' HG21 ' A' ' 107' ' ' VAL . 4.1 m-20 -101.48 138.52 38.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.729 0.3 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.87 112.41 24.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.014 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.669 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -70.12 111.13 5.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.726 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.451 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.5 mt -99.74 -28.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.446 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 1.1 mt-10 -151.68 163.19 39.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.032 0.444 . . . . 0.0 111.983 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 82' ' ' LEU . 90.2 t -144.4 109.16 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.246 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m120 57.61 30.11 18.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.516 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.75 23.04 43.85 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.352 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.611 HG11 HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -108.37 130.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 0.0 111.153 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -75.81 96.25 3.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 110.65 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.983 HD22 HG13 ' A' ' 90' ' ' VAL . 16.3 mt -63.16 -32.44 73.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.11 80.48 0.13 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.62 -25.58 0.22 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.879 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.556 ' HE3' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -90.46 -97.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.802 0.301 . . . . 0.0 111.304 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.88 178.45 0.34 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.763 0.316 . . . . 0.0 110.616 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -68.72 -54.56 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.911 0.386 . . . . 0.0 110.045 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -30.24 71.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.874 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' CB ' ' HB2' ' A' ' 85' ' ' LYS . 21.8 mt-10 -72.96 -49.41 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.815 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.983 HG13 HD22 ' A' ' 82' ' ' LEU . 75.9 t -62.06 -44.61 99.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.332 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.905 HG22 HD11 ' A' ' 38' ' ' ILE . 61.7 t -62.5 -32.8 56.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -38.01 89.48 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.968 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD13 HG11 ' A' ' 80' ' ' VAL . 6.5 mt -60.46 -51.73 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.258 0.551 . . . . 0.0 109.781 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -67.56 -33.92 76.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.07 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -30.61 66.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.722 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.1 t -66.65 -32.33 73.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.972 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.922 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -53.85 137.24 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.846 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.11 175.64 5.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.756 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.96 147.72 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.717 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 60.36 84.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.44 103.85 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.953 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.57 HG22 ' HB3' ' A' ' 26' ' ' GLN . 24.3 m -70.77 109.67 5.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.965 0.412 . . . . 0.0 111.177 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 97' ' ' THR . 67.6 t -94.83 116.56 36.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.7 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -84.94 98.7 10.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.406 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.585 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -95.7 122.23 38.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.266 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.606 HD11 ' HD3' ' A' ' 22' ' ' ARG . 15.7 tp -84.16 123.04 29.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.871 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' OD2' ' A' ' 72' ' ' ASP . 15.0 m -124.84 162.6 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.874 0.369 . . . . 0.0 111.396 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.8 t80 -131.44 127.64 37.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.614 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.19 145.19 29.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -145.65 113.97 6.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.29 169.05 18.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.025 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 111.23 21.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.6 ttmm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.761 0.315 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.64 176.21 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 112' ' ' GLU . 2.2 p -84.11 159.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 19' ' ' VAL . . . 102.49 149.67 22.02 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.692 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' CE ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.62 146.79 50.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.729 0.3 . . . . 0.0 110.627 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -89.3 144.52 26.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.209 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD21 ' CE ' ' A' ' 21' ' ' LYS . 1.5 mt -126.83 150.08 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.19 116.68 32.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.203 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -122.9 127.07 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 0.0 111.801 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.69 123.19 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.067 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 34' ' ' LEU . 60.6 mt -112.0 127.35 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.084 0.469 . . . . 0.0 111.821 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -88.33 114.58 25.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.774 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 10.7 tptp -55.3 144.16 25.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.008 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.5 55.04 0.3 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.811 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.848 HG23 ' HG2' ' A' ' 99' ' ' MET . 0.1 OUTLIER 48.64 29.83 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.817 0.341 . . . . 0.0 111.434 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -144.04 35.62 1.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.0 -133.5 41.11 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.209 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD13 ' HE2' ' A' ' 36' ' ' PHE . 75.9 mt -138.42 9.97 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 54.56 20.55 17.81 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.692 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.536 ' HE2' HD13 ' A' ' 34' ' ' LEU . 4.8 p90 -143.34 127.71 17.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 111.43 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.8 134.77 53.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.951 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.91 HD12 HG21 ' A' ' 51' ' ' ILE . 22.3 pt -110.72 140.21 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.303 0.573 . . . . 0.0 112.32 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -102.94 167.09 10.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.281 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 p -109.42 126.83 53.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.145 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' CD ' ' CG ' ' A' ' 50' ' ' PRO . 10.9 ttt180 -59.71 -24.72 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.974 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.27 82.15 0.19 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.992 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 23.6 t -104.77 -66.66 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.07 161.29 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.013 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.63 113.26 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.34 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.27 25.59 26.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.75 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.63 -128.56 6.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.451 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.87 105.0 14.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.827 0.346 . . . . 0.0 110.836 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.93 129.0 22.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 84.0 Cg_endo -77.02 139.15 19.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.471 2.114 . . . . 0.0 112.702 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.91 HG21 HD12 ' A' ' 38' ' ' ILE . 3.1 mm -105.68 141.38 21.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.268 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 50' ' ' PRO . 3.3 m-85 -132.7 166.76 21.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.531 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 68' ' ' LEU . 45.8 t -87.31 99.09 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.466 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -55.88 -31.63 62.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.301 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 178.49 153.9 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.228 0.537 . . . . 0.0 112.231 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.729 HD11 ' C ' ' A' ' 69' ' ' LYS . 22.6 mm -96.48 105.09 16.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.23 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 63' ' ' ILE . 13.4 mt -56.84 153.48 22.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.389 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' CD1' ' A' ' 63' ' ' ILE . 93.2 Cg_endo -84.11 23.37 0.84 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.903 2.402 . . . . 0.0 113.617 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -159.33 93.3 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.88 0.371 . . . . 0.0 111.034 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . 178.67 -178.05 48.6 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.504 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.63 61.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.714 0.293 . . . . 0.0 111.502 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -56.0 -55.06 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.645 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 57' ' ' LEU . 3.4 tt -56.45 -35.88 45.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 0.0 111.66 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -71.23 -46.79 60.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.126 0.488 . . . . 0.0 110.505 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -33.6 76.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.957 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.75 30.06 75.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.616 ' HB2' HG23 ' A' ' 25' ' ' ILE . 12.9 mtt180 -97.89 -59.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.912 0.387 . . . . 0.0 110.964 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.896 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -97.55 122.87 41.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.523 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.729 ' C ' HD11 ' A' ' 56' ' ' ILE . 28.4 mttt -111.67 -169.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.85 167.19 19.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.018 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.15 13.5 67.21 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.545 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' OD2' HG21 ' A' ' 107' ' ' VAL . 1.1 m-20 -90.82 161.43 15.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.733 0.301 . . . . 0.0 110.739 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 116.33 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.733 ' CD1' HG21 ' A' ' 38' ' ' ILE . 4.3 mt -73.81 109.59 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 108' ' ' PHE . 6.6 mt -94.6 -29.7 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.321 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.85 164.49 36.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.142 0.496 . . . . 0.0 111.76 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.784 ' CG2' HD21 ' A' ' 82' ' ' LEU . 95.6 t -146.83 110.61 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.716 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 61.02 30.99 19.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.39 14.78 67.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.132 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.84 148.31 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.909 0.385 . . . . 0.0 111.318 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -86.57 118.19 25.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.398 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.784 HD21 ' CG2' ' A' ' 77' ' ' VAL . 4.2 mt -85.92 20.14 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.3 84.78 2.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.943 0.402 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.72 22.77 5.27 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.525 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.658 ' NZ ' HD23 ' A' ' 82' ' ' LEU . 12.2 mtmt -102.6 -93.02 0.32 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.876 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.841 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.51 155.7 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.8 tt0 -68.73 -54.4 16.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.91 -30.12 68.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.462 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.417 ' HG3' ' HB2' ' A' ' 86' ' ' SER . 4.0 mm-40 -71.11 -53.91 12.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.612 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 86' ' ' SER . 89.8 t -56.71 -44.38 81.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.444 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 34.9 t -64.85 -32.25 57.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.904 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 -33.47 76.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.404 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.6 mt -68.49 -52.44 32.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.032 0.444 . . . . 0.0 110.122 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 91' ' ' VAL . 2.8 pp -67.19 -36.1 81.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.69 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HG3' HG12 ' A' ' 91' ' ' VAL . 1.1 mtp-105 -72.4 -30.8 64.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.682 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -64.93 -29.97 70.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.704 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.92 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -58.97 135.67 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.549 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 172.02 7.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.848 ' HG2' HG23 ' A' ' 31' ' ' THR . 0.0 OUTLIER -48.29 149.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.552 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.61 76.23 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.74 105.37 0.21 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.592 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 107.78 4.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.928 0.394 . . . . 0.0 111.327 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.92 ' CG2' HG21 ' A' ' 97' ' ' THR . 17.7 t -94.51 120.67 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.074 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.41 136.52 33.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mt -137.65 106.81 6.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.2 tp -83.17 110.96 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.918 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 25' ' ' ILE . 12.2 m -104.76 171.64 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.648 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.64 ' HB2' HD11 ' A' ' 75' ' ' ILE . 48.2 t80 -138.15 118.13 13.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.895 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.35 108.29 19.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.447 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -133.16 140.41 47.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -179.86 84.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.225 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HB2' HG11 ' A' ' 19' ' ' VAL . 2.5 tt0 -88.89 -27.92 20.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.616 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.447 -179.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.737 0.303 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.78 31.16 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 20' ' ' GLY . 1.4 p -110.66 -167.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.838 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 19' ' ' VAL . . . 116.43 174.35 17.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.554 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.651 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.06 149.51 29.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 110.606 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -96.18 149.38 21.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.251 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.723 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.62 156.09 45.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.36 121.47 41.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.361 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -129.09 135.27 62.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.964 0.411 . . . . 0.0 111.617 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.61 122.55 43.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 141.47 45.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.125 0.488 . . . . 0.0 111.785 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.97 116.44 23.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.442 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 99' ' ' MET . 6.3 tptt -50.22 134.36 22.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.373 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.55 176.6 20.49 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.386 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.48 -40.14 73.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.82 0.343 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -87.11 57.56 4.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.962 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.42 -143.68 41.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 94' ' ' LEU . 7.2 mt -110.92 -24.79 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.672 0.272 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.509 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 103.75 14.2 25.79 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.229 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HB2' HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -148.16 135.81 20.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.358 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.13 134.47 49.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 23.1 pt -111.51 139.64 34.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.429 0.633 . . . . 0.0 112.46 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.2 OUTLIER -101.45 170.09 8.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.608 178.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 127.18 29.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.945 0.402 . . . . 0.0 111.408 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HD2' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -68.29 -30.63 69.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.487 179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 59.38 73.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.251 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.649 HG23 ' HD2' ' A' ' 50' ' ' PRO . 39.1 t -70.0 -49.58 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.69 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.519 HG23 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -141.96 161.57 37.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.139 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.58 117.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.212 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.87 26.81 48.77 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.705 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' A' ' 44' ' ' THR . . . -112.1 -133.72 6.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.497 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.2 105.71 16.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.993 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' HG23 ' A' ' 43' ' ' VAL . . . -126.37 126.43 24.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.773 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.649 ' HD2' HG23 ' A' ' 43' ' ' VAL . 60.2 Cg_endo -72.21 135.93 25.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.561 2.174 . . . . 0.0 112.85 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.6 mm -102.61 140.05 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.897 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB2' HG23 ' A' ' 39' ' ' THR . 7.8 m-85 -128.09 174.44 9.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.728 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 56' ' ' ILE . 39.0 t -94.19 98.7 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.729 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -58.7 -32.94 69.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.072 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 176.32 153.63 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.163 0.506 . . . . 0.0 112.086 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 36' ' ' PHE . 32.5 mm -105.59 129.45 58.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.061 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 12.7 mt -87.49 134.12 36.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.722 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 63' ' ' ILE . 27.1 Cg_exo -62.69 -13.37 33.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.985 2.457 . . . . 0.0 113.355 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.96 74.25 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.858 0.361 . . . . 0.0 111.206 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -161.16 -176.6 33.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.925 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.64 -45.72 35.67 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.88 -54.72 41.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.4 tt -61.82 -37.35 77.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 3.5 pt20 -71.73 -32.66 67.99 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.282 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -71.5 -33.82 69.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.552 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.89 61.11 6.45 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.246 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' ILE . 64.1 mtt180 -139.52 -47.41 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 111.256 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.895 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.18 121.11 44.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' O ' HD12 ' A' ' 68' ' ' LEU . 11.7 mmtt -107.87 -170.89 1.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.5 163.65 22.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.07 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.9 11.95 83.99 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.76 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.44 158.49 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.323 . . . . 0.0 110.733 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -115.25 121.67 43.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -69.99 113.18 6.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.014 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.3 mt -99.74 -27.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -160.67 140.58 11.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.023 0.439 . . . . 0.0 111.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.935 HG23 HD23 ' A' ' 105' ' ' LEU . 9.4 p -126.5 125.96 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.034 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.598 HD21 HG13 ' A' ' 103' ' ' VAL . 10.9 m120 51.18 29.87 5.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.886 0.374 . . . . 0.0 111.091 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.85 18.77 62.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.846 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.2 t -108.17 142.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.817 0.341 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.52 110.53 13.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.396 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD22 HG22 ' A' ' 90' ' ' VAL . 24.8 mt -90.45 25.17 2.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.77 32.84 2.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.64 42.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.078 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -122.69 -108.71 0.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 110.809 -0.071 . . . . 0.0 110.809 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.734 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER 177.6 169.03 0.66 Allowed 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.679 0.276 . . . . 0.0 110.348 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 31.2 tt0 -68.35 -54.72 15.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.078 0.466 . . . . 0.0 110.011 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.01 -30.57 71.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.404 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -69.46 -50.76 42.53 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.414 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.84 HG22 HD22 ' A' ' 82' ' ' LEU . 54.4 t -59.34 -50.42 79.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.311 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 21.9 t -61.46 -32.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.118 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -38.23 90.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.798 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 77' ' ' VAL . 5.2 mt -66.11 -52.42 48.76 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.222 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.614 HD13 HD12 ' A' ' 34' ' ' LEU . 2.2 pp -67.42 -28.65 68.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.59 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.86 ' CD ' HG12 ' A' ' 91' ' ' VAL . 13.4 mtp180 -71.8 -30.92 66.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.469 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 t -67.96 -31.03 70.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.67 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.087 HG21 HG22 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -52.97 138.01 31.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.71 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.23 157.39 17.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.673 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.481 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 10.7 mmt -47.42 162.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.503 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 55.39 61.22 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.123 0.487 . . . . 0.0 110.031 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.08 107.02 0.25 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 2.5 m -69.82 117.7 11.75 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.091 0.472 . . . . 0.0 111.217 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.087 HG22 HG21 ' A' ' 97' ' ' THR . 41.7 t -94.29 126.67 46.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -84.93 136.95 33.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 110.763 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.935 HD23 HG23 ' A' ' 77' ' ' VAL . 3.6 mt -138.31 107.82 6.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 75' ' ' ILE . 9.0 tp -85.85 110.81 19.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.777 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 25' ' ' ILE . 19.0 m -106.03 172.18 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.949 0.404 . . . . 0.0 111.552 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -131.0 120.74 23.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.53 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.723 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -107.8 145.03 34.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -89.2 156.53 18.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.728 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -66.32 -175.18 0.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.03 71.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -112.15 133.4 54.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 20' ' ' GLY . 0.6 OUTLIER -115.64 -164.05 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.692 ' N ' HG13 ' A' ' 19' ' ' VAL . . . 94.26 155.56 31.76 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -149.98 166.81 28.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.852 0.358 . . . . 0.0 110.79 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.5 ptt180 -108.63 136.37 48.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.511 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -117.62 155.85 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.131 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -108.85 112.64 25.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.898 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.8 mp -115.31 128.58 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.026 0.441 . . . . 0.0 111.834 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.4 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.2 mp0 -111.96 118.7 36.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.074 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 62' ' ' ALA . 6.7 mt -111.78 131.93 54.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 111.686 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -80.44 116.84 20.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.716 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 136.82 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.992 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.73 -136.84 3.68 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.86 -30.44 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 111.009 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.48 53.75 1.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.34 -131.11 51.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 94' ' ' LEU . 11.7 mt -114.84 -33.62 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.735 0.303 . . . . 0.0 110.751 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 111.39 14.93 10.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.952 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.7 p90 -158.94 137.22 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.416 . . . . 0.0 111.76 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' LYS . 2.6 m -106.48 134.92 48.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 HG22 ' A' ' 91' ' ' VAL . 14.4 pt -102.83 142.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -107.32 170.98 7.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.82 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 87' ' ' GLN . 13.9 t -128.56 128.67 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.788 0.328 . . . . 0.0 111.09 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -67.64 -27.9 67.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.996 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.13 50.89 3.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.653 HG23 ' HD2' ' A' ' 50' ' ' PRO . 48.6 t -60.13 -81.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.525 HG23 HG12 ' A' ' 43' ' ' VAL . 6.9 p -100.91 126.51 47.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.149 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.83 130.09 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.434 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.68 21.3 0.71 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.732 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.01 103.86 8.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.975 0.416 . . . . 0.0 110.885 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.25 140.73 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.777 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 43' ' ' VAL . 73.5 Cg_endo -76.33 132.37 13.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.519 2.146 . . . . 0.0 112.734 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 38' ' ' ILE . 7.3 mm -94.96 143.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.094 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 73' ' ' ARG . 75.4 m-85 -131.08 174.79 9.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.758 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 56' ' ' ILE . 41.0 t -90.6 101.82 12.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.008 0.432 . . . . 0.0 110.927 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.66 -30.88 70.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.9 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -175.79 151.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.11 0.481 . . . . 0.0 112.119 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -112.14 97.51 5.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.153 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.6 mt -54.19 142.71 47.15 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.562 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.776 ' HA ' HD13 ' A' ' 63' ' ' ILE . 71.8 Cg_endo -74.31 -23.75 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.912 2.408 . . . . 0.0 112.969 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.26 70.44 0.73 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.381 . . . . 0.0 110.814 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -150.34 179.86 26.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.614 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.53 -38.95 58.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.635 0.255 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.781 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -57.96 -55.95 28.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.382 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.776 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.7 tt -63.56 -38.72 82.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.916 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 34.9 tt0 -67.24 -34.49 77.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.559 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.6 -33.74 69.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.461 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 55.4 15.96 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.324 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.673 ' HB2' HG23 ' A' ' 25' ' ' ILE . 33.4 mtt180 -139.05 -49.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.898 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.17 119.85 40.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.751 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.477 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.1 mttm -110.6 -169.19 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.945 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.95 177.94 8.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.892 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.15 20.1 48.54 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.607 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.29 151.22 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.72 0.295 . . . . 0.0 110.717 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 8.3 ttm180 -108.23 116.24 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.231 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 2.4 mp -67.47 120.23 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.21 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.72 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -104.35 -27.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.659 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 37.4 mt-10 -157.98 153.33 25.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.533 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.039 HG23 HD11 ' A' ' 82' ' ' LEU . 96.5 t -138.19 124.72 26.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.469 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 m120 56.39 30.85 17.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.79 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.93 14.54 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.715 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG1' ' HE3' ' A' ' 85' ' ' LYS . 92.9 t -108.32 149.53 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.375 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.582 ' OD2' ' HB3' ' A' ' 83' ' ' ALA . 23.9 t70 -88.46 117.5 27.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.389 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.039 HD11 HG23 ' A' ' 77' ' ' VAL . 4.4 mt -89.44 19.3 4.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.156 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HB3' ' OD2' ' A' ' 81' ' ' ASP . . . -94.58 72.83 3.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.3 39.66 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.34 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CG1' ' A' ' 80' ' ' VAL . 20.7 mttt -125.06 -89.93 0.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.499 0.19 . . . . 0.0 111.05 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 167.69 160.52 0.04 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.388 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.863 ' O ' HG23 ' A' ' 91' ' ' VAL . 40.5 tt0 -68.8 -54.63 14.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.095 0.474 . . . . 0.0 110.11 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.592 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.2 mm-40 -70.6 -50.87 32.64 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.527 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 86' ' ' SER . 54.8 t -58.43 -47.42 88.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.235 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 87' ' ' GLN . 38.2 t -62.21 -32.29 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.964 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.3 -34.97 79.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.277 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 4.7 mt -67.34 -52.35 41.32 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.02 0.438 . . . . 0.0 110.28 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 34' ' ' LEU . 2.4 pp -68.33 -31.95 71.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HG3' HG12 ' A' ' 91' ' ' VAL . 72.8 mtt180 -72.61 -30.66 64.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.749 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.8 p -61.1 -36.61 80.14 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.211 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.03 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -50.95 132.18 27.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.811 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.45 -177.89 3.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.688 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.35 145.42 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.504 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 60.7 84.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.49 105.24 0.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.767 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 26' ' ' GLN . 29.8 m -70.72 112.09 6.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.098 0.475 . . . . 0.0 111.239 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.03 ' CG2' HG21 ' A' ' 97' ' ' THR . 53.4 t -94.97 113.11 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.197 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -84.93 117.3 23.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.03 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.568 HD23 HG22 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -122.91 116.39 23.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.72 HD23 ' HB ' ' A' ' 75' ' ' ILE . 4.0 tp -86.52 110.59 19.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.316 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.2 m -105.04 171.53 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.215 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 26.4 t80 -124.73 116.24 22.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.568 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 23' ' ' LEU . 4.6 tpp85 -97.78 145.11 26.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -113.69 140.8 47.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.82 159.37 16.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.823 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -98.65 34.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -142.26 139.82 32.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.9 t -132.02 160.22 42.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 150.99 165.24 12.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.558 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.566 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -140.74 143.14 34.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.711 0.291 . . . . 0.0 110.723 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.7 OUTLIER -101.72 152.5 20.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 111.25 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -134.41 155.05 50.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.0 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.08 122.53 47.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.318 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -133.63 116.93 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HB2' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -105.34 142.52 34.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.907 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -126.07 126.02 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.309 0.576 . . . . 0.0 112.184 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -75.21 108.7 8.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.535 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.3 OUTLIER -50.18 137.34 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.011 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.38 46.97 0.79 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.031 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.681 HG22 ' CG ' ' A' ' 99' ' ' MET . 2.4 p 69.03 -58.7 0.49 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -71.91 56.7 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.954 0.407 . . . . 0.0 111.171 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 49.77 -135.05 25.68 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.663 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 27' ' ' LEU . 66.1 mt -120.42 -30.62 4.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.686 0.279 . . . . 0.0 111.134 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 107.25 15.54 15.63 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.054 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' HE1' HD13 ' A' ' 34' ' ' LEU . 21.9 p90 -151.95 137.31 17.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.931 0.396 . . . . 0.0 111.442 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.3 m -106.27 134.64 49.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.629 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 51' ' ' ILE . 25.3 pt -105.94 140.95 22.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.404 0.621 . . . . 0.0 112.416 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.59 171.25 7.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.979 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.4 p -133.06 144.12 49.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.863 0.364 . . . . 0.0 111.078 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -53.55 -24.57 13.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.085 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.77 41.06 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.045 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 44' ' ' THR . 2.5 p -70.96 -46.56 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.042 0.449 . . . . 0.0 110.693 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.967 HG22 HG13 ' A' ' 43' ' ' VAL . 6.0 t -162.91 172.57 14.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.998 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -66.75 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.132 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.5 76.55 0.32 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.486 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.45 -124.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.427 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.79 106.75 6.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.78 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.624 ' HB2' HG12 ' A' ' 43' ' ' VAL . . . -126.69 125.25 24.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.011 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.67 137.34 29.91 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.43 2.087 . . . . 0.0 112.406 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.79 HG13 HG21 ' A' ' 90' ' ' VAL . 4.9 mm -96.37 151.89 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 21.7 m-85 -143.24 174.52 10.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG11 HD11 ' A' ' 56' ' ' ILE . 45.1 t -96.63 99.01 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.857 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -32.12 59.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.91 151.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.803 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HG11 ' A' ' 53' ' ' VAL . 30.5 mm -102.79 96.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.2 mt -53.06 148.75 13.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.41 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.4 Cg_endo -85.0 29.12 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.015 2.477 . . . . 0.0 113.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -158.76 89.4 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.99 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . 179.37 -173.68 45.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.695 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.526 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.69 -40.51 55.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.49 -55.28 33.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.8 tt -60.33 -40.07 82.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 19.8 pt20 -71.44 -33.66 69.58 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.523 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -71.42 -33.81 69.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.587 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.61 59.96 8.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.268 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.9 mtt180 -137.48 -44.25 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.612 0.244 . . . . 0.0 111.379 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.94 120.38 41.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.438 . . . . 0.0 110.871 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.4 mmtt -109.33 -170.21 1.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.927 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.84 157.76 24.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.45 -10.13 75.39 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.0 154.31 22.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.689 0.281 . . . . 0.0 110.855 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' TYR . 8.0 ptm180 -111.59 134.01 53.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.914 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 4.6 mp -78.29 114.16 16.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.39 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.3 mt -84.78 -29.17 6.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 3.0 pt-20 -168.56 154.29 6.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.892 HG23 HD21 ' A' ' 82' ' ' LEU . 46.2 t -126.71 127.75 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.543 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.7 m120 57.0 28.66 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.786 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.38 9.52 72.54 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.83 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG11 ' HE3' ' A' ' 85' ' ' LYS . 70.4 t -108.17 118.08 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.341 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 5.9 m-20 -65.51 118.22 9.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.892 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -84.02 18.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.255 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.26 85.75 6.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.374 . . . . 0.0 110.747 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.7 16.56 4.97 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.649 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.572 ' HE3' HG11 ' A' ' 80' ' ' VAL . 16.2 mttm -98.14 -98.03 0.21 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.673 0.236 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.97 168.33 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.643 0.259 . . . . 0.0 110.548 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.867 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -68.4 -54.51 16.66 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -63.76 -30.79 71.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.534 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 5.3 mm-40 -69.96 -52.26 25.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.482 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG21 HG13 ' A' ' 51' ' ' ILE . 62.4 t -58.41 -49.34 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.503 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 87' ' ' GLN . 33.7 t -62.35 -32.38 54.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.331 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -37.05 85.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.63 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.3 mt -66.61 -52.49 44.6 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.445 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.8 pp -65.69 -31.83 73.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.893 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.817 ' CD ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -72.03 -30.69 65.44 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 110.749 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.95 -35.03 72.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.93 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -59.47 131.8 52.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.722 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.9 -176.72 3.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.503 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.681 ' CG ' HG22 ' A' ' 31' ' ' THR . 0.0 OUTLIER -50.37 141.97 11.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.541 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 61.48 81.92 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.956 0.408 . . . . 0.0 110.289 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -175.17 103.43 0.18 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.846 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.571 HG22 ' HB2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -70.96 112.18 6.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.953 0.406 . . . . 0.0 111.249 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.93 ' CG2' HG21 ' A' ' 97' ' ' THR . 16.2 t -94.58 113.29 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.072 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.7 OUTLIER -84.59 112.44 20.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.814 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.491 ' HG ' HG12 ' A' ' 103' ' ' VAL . 1.1 mp -114.7 109.69 18.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.396 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.7 tp -80.55 114.24 19.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.992 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.619 HG22 HD12 ' A' ' 25' ' ' ILE . 14.1 m -104.73 172.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.498 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' A' ' 75' ' ' ILE . 8.0 t80 -144.9 128.64 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.48 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 23' ' ' LEU . 14.4 ptp180 -127.57 143.95 51.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -66.25 149.81 49.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.999 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -85.22 165.91 16.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.47 72.86 5.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 61.05 166.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.3 t -91.7 160.0 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 169.47 148.71 5.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.464 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.74 ' CE ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.61 133.86 55.33 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.719 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 6.0 mtt85 -87.87 128.06 35.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.954 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.846 HD12 HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -106.3 143.8 33.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.053 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -107.28 120.82 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.12 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.894 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.2 mp -128.9 149.53 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.043 0.449 . . . . 0.0 111.742 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -132.58 144.32 50.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.043 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 62' ' ' ALA . 30.7 mt -137.9 115.39 11.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 18.1 tptt -72.91 104.71 4.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.312 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 15.3 tttp -56.45 137.43 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.237 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 31' ' ' THR . . . -149.85 -62.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 30' ' ' GLY . 1.5 p -156.75 161.66 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.844 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 59.55 55.49 4.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.13 -128.67 46.31 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.431 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.2 mt -116.97 -34.34 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 113.73 17.57 7.4 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.129 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 34' ' ' LEU . 50.8 p90 -162.09 135.11 6.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.389 . . . . 0.0 111.343 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.48 134.39 49.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 91' ' ' VAL . 25.7 pt -106.29 139.77 26.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.359 0.6 . . . . 0.0 112.167 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 51' ' ' ILE . 0.5 OUTLIER -108.32 168.2 9.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.205 179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 p -112.04 135.59 52.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.01 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HB3' HG23 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -59.12 -17.79 29.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.44 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.44 51.94 1.93 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.939 0.399 . . . . 0.0 110.781 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 50' ' ' PRO . 34.1 t -86.95 -67.23 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.42 156.98 25.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.973 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.24 65.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.3 28.28 56.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.503 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.51 71.24 0.5 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.503 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 78.55 104.34 0.07 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.005 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.57 125.23 3.43 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.571 ' HD2' HG21 ' A' ' 43' ' ' VAL . 35.8 Cg_endo -65.04 135.58 44.48 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 38' ' ' ILE . 5.1 mm -100.81 145.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.214 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 73' ' ' ARG . 4.9 m-85 -136.38 142.96 43.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 68' ' ' LEU . 40.0 t -59.72 100.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.033 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' CA ' HG22 ' A' ' 39' ' ' THR . 27.7 tptt -55.88 -34.41 65.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.802 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 173.66 147.62 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.147 0.499 . . . . 0.0 111.903 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 63' ' ' ILE . 31.1 mm -96.63 136.67 26.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.767 178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.3 131.91 33.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.699 0.285 . . . . 0.0 111.668 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.926 ' HA ' HD13 ' A' ' 63' ' ' ILE . 53.5 Cg_exo -53.01 -30.8 50.56 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.914 2.409 . . . . 0.0 113.031 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.68 68.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.987 0.422 . . . . 0.0 110.882 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -146.55 174.67 26.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.446 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.24 -42.92 54.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.398 . . . . 0.0 111.236 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -57.83 -51.39 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.552 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.926 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -61.78 -39.31 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.555 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 17.3 pt20 -71.35 -32.17 68.21 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.504 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -33.73 70.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.59 33.33 76.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.302 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' CB ' HG23 ' A' ' 25' ' ' ILE . 2.3 mtt180 -107.32 -64.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 111.102 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.894 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -98.67 122.27 41.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 68' ' ' LEU . 19.4 mttm -106.38 -170.45 1.73 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.087 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.73 155.51 23.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.97 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.75 -18.41 53.08 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.86 161.04 19.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.754 0.312 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HD2' ' CE2' ' A' ' 52' ' ' TYR . 55.2 ttt-85 -117.72 111.62 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -60.23 125.56 24.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.427 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.626 ' HB ' HD23 ' A' ' 106' ' ' LEU . 7.6 mt -113.24 -28.48 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.626 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 57.7 mt-10 -154.44 155.7 35.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HD11 ' A' ' 82' ' ' LEU . 70.0 t -145.88 120.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.409 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.537 ' OD1' HG13 ' A' ' 103' ' ' VAL . 26.5 m120 60.4 30.95 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.5 13.47 80.21 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.866 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.12 149.34 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.91 0.386 . . . . 0.0 111.167 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.71 119.74 28.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.559 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.019 HD11 HG23 ' A' ' 77' ' ' VAL . 20.3 mt -87.42 16.79 5.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.58 109.43 21.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.72 25.07 28.56 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.206 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -107.85 -87.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.491 0.186 . . . . 0.0 110.981 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.753 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.7 154.62 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.477 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.872 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.2 tt0 -68.79 -54.4 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 0.0 109.955 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -62.81 -30.51 71.53 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.679 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.0 mm-40 -70.62 -52.05 23.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.553 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 86' ' ' SER . 76.6 t -57.78 -46.78 87.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.359 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 38' ' ' ILE . 38.7 t -62.53 -32.27 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.996 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.04 -33.32 75.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.03 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -67.27 -52.37 41.48 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' O ' ' OG1' ' A' ' 97' ' ' THR . 2.3 pp -68.88 -29.02 67.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.363 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -72.66 -31.01 64.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.383 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 t -61.61 -40.55 95.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.814 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.974 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -45.89 126.12 6.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -179.45 3.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -75.98 57.29 1.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.785 179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 99' ' ' MET . 1.7 mt-10 160.78 79.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.463 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.05 113.28 0.43 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 57.7 m -68.45 109.36 3.66 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.122 0.487 . . . . 0.0 110.719 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.974 HG22 HG21 ' A' ' 97' ' ' THR . 3.1 t -94.14 111.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.44 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.0 114.22 22.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD23 HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -115.05 118.38 33.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.626 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.0 tp -86.5 115.84 24.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.997 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.846 HG23 HD12 ' A' ' 23' ' ' LEU . 15.8 m -104.49 167.44 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.0 111.527 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.559 ' HB2' HD11 ' A' ' 75' ' ' ILE . 72.3 t80 -128.71 117.58 21.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -102.84 104.76 15.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.781 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -72.74 139.11 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -109.1 110.27 21.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.52 -62.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.164 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 59.93 77.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.9 t -112.44 159.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 63.06 159.23 0.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.543 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.603 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -135.67 144.65 46.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.728 0.299 . . . . 0.0 110.881 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.2 ptt180 -98.51 141.31 31.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.217 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -120.65 155.74 33.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.217 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -109.21 130.97 55.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.138 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.87 HD13 ' HB2' ' A' ' 68' ' ' LEU . 3.1 mp -138.04 126.08 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.21 124.01 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.813 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 62' ' ' ALA . 14.8 mt -114.94 131.34 56.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.184 0.516 . . . . 0.0 112.039 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 tptm -84.76 112.31 20.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.358 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.83 113.81 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 31' ' ' THR . . . -142.39 64.24 0.5 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.236 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 30' ' ' GLY . 13.3 t 49.12 -178.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 111.296 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.502 ' HG3' HG23 ' A' ' 31' ' ' THR . 7.0 mt-10 55.37 34.94 23.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.01 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.42 -148.08 50.43 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.357 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 94' ' ' LEU . 11.1 mt -108.39 -31.69 7.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.86 0.362 . . . . 0.0 110.621 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 111.61 11.41 17.26 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.07 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.537 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 24.3 p90 -161.95 134.5 5.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.932 0.396 . . . . 0.0 111.569 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.61 134.77 49.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.739 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 91' ' ' VAL . 24.1 pt -99.44 140.22 19.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.288 0.566 . . . . 0.0 112.198 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.4 167.07 9.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.27 178.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.3 p -121.24 124.3 44.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -25.91 61.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.09 67.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.595 ' CG1' HG22 ' A' ' 44' ' ' THR . 3.0 p -94.51 -45.97 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.595 HG22 ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -125.43 168.77 13.13 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.968 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.37 -66.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.316 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.81 49.64 0.62 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.76 -102.7 2.53 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.424 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' CB ' ' HA2' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -126.59 105.71 8.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.745 0.307 . . . . 0.0 110.839 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . . . -118.9 139.18 26.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.158 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' ALA . 20.3 Cg_exo -65.76 121.36 8.71 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.655 2.236 . . . . 0.0 112.508 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.487 HD12 ' OE1' ' A' ' 87' ' ' GLN . 3.2 mm -99.8 134.9 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 50' ' ' PRO . 36.4 m-85 -131.7 174.07 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 0.0 111.103 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 56' ' ' ILE . 27.1 t -87.25 98.91 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 3.6 tptp -57.03 -32.81 66.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.049 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -176.66 151.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 112.084 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.761 HD11 HG11 ' A' ' 53' ' ' VAL . 36.0 mm -106.47 100.28 10.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.178 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.3 142.99 57.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.462 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.728 ' HA ' HD13 ' A' ' 63' ' ' ILE . 74.2 Cg_endo -75.13 -19.28 17.72 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.815 2.343 . . . . 0.0 113.309 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.33 71.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.942 0.401 . . . . 0.0 111.022 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.495 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -152.45 179.43 28.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.624 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.44 -40.4 57.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.722 0.296 . . . . 0.0 111.621 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.92 -55.16 36.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.717 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.728 HD13 ' HA ' ' A' ' 58' ' ' PRO . 4.4 tt -61.78 -41.45 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -71.75 -30.8 66.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.803 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 64' ' ' GLN . 16.7 t0 -71.83 -33.98 68.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.929 0.395 . . . . 0.0 110.796 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.98 62.21 4.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.194 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 25' ' ' ILE . 17.1 mtp180 -138.99 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 0.0 111.295 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.87 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -94.01 126.22 39.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 68' ' ' LEU . 27.3 mttt -111.03 -168.43 1.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.976 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -81.73 172.35 13.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.48 25.25 68.49 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.435 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.01 157.83 16.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' HG3' ' CE1' ' A' ' 52' ' ' TYR . 63.0 ttt180 -115.22 113.94 24.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.847 ' HB3' HD12 ' A' ' 82' ' ' LEU . 4.9 mp -62.75 118.38 7.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.733 HD11 ' HB2' ' A' ' 108' ' ' PHE . 4.5 mt -91.52 -28.72 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.494 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.478 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 2.6 pp20? -177.85 165.94 2.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.202 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.057 HG23 HD11 ' A' ' 82' ' ' LEU . 99.4 t -140.28 124.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.552 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' OD1' HG12 ' A' ' 77' ' ' VAL . 6.8 m120 55.34 29.76 13.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.964 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.25 9.53 67.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.825 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' ' 85' ' ' LYS . 72.9 t -108.08 119.44 57.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 111.2 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -71.21 116.1 11.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.057 HD11 HG23 ' A' ' 77' ' ' VAL . 13.4 mt -84.02 21.76 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.006 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.47 46.17 1.14 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 0.0 110.942 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 48' ' ' SER . . . 152.11 44.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.344 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -124.59 -83.67 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.577 0.227 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.808 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.26 158.32 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.763 0.316 . . . . 0.0 110.524 179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.0 tp60 -68.6 -52.47 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -30.19 71.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.676 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -73.05 -46.4 52.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.177 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -66.89 -42.16 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.673 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.1 t -69.81 -32.41 51.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.3 t -68.23 -46.72 69.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.685 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.713 HD21 ' HA ' ' A' ' 90' ' ' VAL . 0.8 OUTLIER -61.59 -38.54 87.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.224 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 34' ' ' LEU . 1.6 pp -77.86 -31.37 51.42 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.583 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.649 ' HD3' HG12 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.7 -30.87 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.959 0.409 . . . . 0.0 110.375 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -55.84 -38.57 70.24 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.938 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.909 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -53.59 130.83 37.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.17 -172.98 2.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 mmt -47.25 142.51 3.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.972 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 58.54 71.92 0.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.942 0.401 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.98 101.44 0.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.842 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.19 8.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.926 0.393 . . . . 0.0 111.009 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.909 HG22 HG21 ' A' ' 97' ' ' THR . 2.6 t -94.21 114.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.133 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.43 125.67 32.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 0.0 110.854 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -134.24 120.07 19.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 23' ' ' LEU . 27.3 tp -94.73 127.15 40.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.683 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 25' ' ' ILE . 24.7 m -117.16 164.38 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.878 0.371 . . . . 0.0 111.373 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' HD11 ' A' ' 75' ' ' ILE . 11.0 t80 -133.76 122.0 22.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.647 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -106.38 108.73 20.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.93 127.9 34.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -93.04 147.33 22.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.019 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -104.17 94.5 5.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.712 0.291 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.57 77.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.981 0.42 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.9 t -128.86 8.06 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.37 151.1 42.97 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.74 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.743 ' HD2' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -155.6 139.56 16.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 0.0 110.642 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 ppt_? -90.01 146.87 24.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.41 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.743 HD21 ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -131.86 154.63 48.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.115 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.46 116.76 33.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.681 HD12 ' CG2' ' A' ' 107' ' ' VAL . 9.0 mt -130.68 118.32 41.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.38 . . . . 0.0 111.862 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -112.96 155.27 25.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.906 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.619 HD12 ' HE2' ' A' ' 36' ' ' PHE . 96.6 mt -131.19 128.51 40.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 112.193 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -77.5 110.37 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.263 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 0.6 OUTLIER -47.68 127.81 12.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.433 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.23 -84.34 0.17 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.585 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.53 159.17 43.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 57.37 66.29 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.037 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.42 -120.69 21.08 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 34' ' ' LEU . 7.0 mt -123.53 -36.96 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.544 0.211 . . . . 0.0 110.92 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . . . 119.21 11.51 7.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.08 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HE2' HD12 ' A' ' 27' ' ' LEU . 28.4 p90 -155.1 136.59 14.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.9 0.381 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.3 134.75 48.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.612 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD11 HG22 ' A' ' 91' ' ' VAL . 21.1 pt -105.03 139.33 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.236 0.541 . . . . 0.0 112.162 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.39 168.51 9.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.178 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 129.82 43.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.815 0.34 . . . . 0.0 111.139 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HD3' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -60.34 -26.01 66.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.795 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.46 48.51 4.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.583 HG23 ' HD2' ' A' ' 50' ' ' PRO . 61.6 t -61.18 -71.08 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.995 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 p -102.68 147.1 27.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.011 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.71 -29.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.358 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.59 76.13 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.415 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.97 -83.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -132.34 120.27 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.0 129.8 9.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.73 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 43' ' ' VAL . 73.0 Cg_endo -75.97 140.96 23.44 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.474 2.116 . . . . 0.0 112.896 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 90' ' ' VAL . 2.6 mm -105.95 151.51 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 22.9 m-85 -145.1 174.15 11.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 56' ' ' ILE . 21.5 t -84.96 98.96 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 0.0 110.872 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 tttm -59.91 -33.89 72.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.18 147.86 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.174 0.511 . . . . 0.0 112.18 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.688 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -103.42 115.47 45.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.885 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.3 mt -69.74 136.56 87.86 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.837 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.69 ' HA ' HD13 ' A' ' 63' ' ' ILE . 22.6 Cg_exo -64.96 -12.6 35.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.928 2.418 . . . . 0.0 113.232 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 77.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' CA ' ' A' ' 35' ' ' GLY . . . -157.08 -179.19 31.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.873 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.44 -40.42 57.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 27' ' ' LEU . . . -56.67 -55.58 32.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.356 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.4 tt -61.17 -40.26 85.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.031 0.443 . . . . 0.0 111.31 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.425 ' N ' ' CG2' ' A' ' 63' ' ' ILE . 31.0 tt0 -68.44 -34.99 76.95 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.86 -33.83 68.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.612 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.12 54.1 29.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.166 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 25' ' ' ILE . 47.0 mtp180 -133.32 -45.31 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.709 0.29 . . . . 0.0 111.292 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.608 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -114.5 119.9 38.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.051 0.453 . . . . 0.0 110.909 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' O ' HD12 ' A' ' 68' ' ' LEU . 2.2 mmtt -109.93 -170.86 1.73 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.82 160.49 24.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.085 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 7.11 87.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.74 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.26 164.02 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.712 0.292 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 72.4 ttt180 -116.36 119.09 34.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' HD13 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -73.82 109.69 7.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.067 0.461 . . . . 0.0 111.025 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -93.61 -29.38 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.235 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.7 mt-10 -158.37 150.12 21.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 111.475 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 82' ' ' LEU . 71.2 t -138.18 123.67 24.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.219 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.38 28.63 18.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.57 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.18 11.73 84.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.106 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG12 ' HZ3' ' A' ' 85' ' ' LYS . 34.0 t -108.58 138.14 36.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.409 . . . . 0.0 111.448 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.1 118.84 16.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.378 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 77' ' ' VAL . 2.0 mt -84.82 19.84 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.955 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.48 104.27 16.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.858 0.361 . . . . 0.0 110.781 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.34 20.74 21.94 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.209 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.909 ' HE3' HD11 ' A' ' 93' ' ' LEU . 6.3 mtmm -101.32 -94.48 0.28 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.452 0.167 . . . . 0.0 110.851 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.811 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.1 t 163.77 163.12 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.795 0.331 . . . . 0.0 110.266 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.84 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.3 tp-100 -68.86 -54.25 16.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.054 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -30.29 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.729 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 4.6 mm-40 -71.29 -52.78 17.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.624 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 86' ' ' SER . 87.1 t -57.72 -44.98 86.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.318 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.842 HG12 ' HG3' ' A' ' 95' ' ' ARG . 42.1 t -65.16 -32.27 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.853 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -35.2 79.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.405 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.909 HD11 ' HE3' ' A' ' 85' ' ' LYS . 5.5 mt -67.74 -52.61 35.39 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.213 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 94' ' ' LEU . 3.1 pp -68.22 -30.01 68.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.413 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.842 ' HG3' HG12 ' A' ' 91' ' ' VAL . 6.0 mtp180 -72.33 -31.87 66.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.322 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -45.21 88.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.1 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.789 HG21 HG22 ' A' ' 103' ' ' VAL . 0.6 OUTLIER -51.42 121.37 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.601 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -171.4 1.93 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.165 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 28.5 mmt -46.03 136.13 6.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.24 83.57 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.918 0.39 . . . . 0.0 110.276 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.69 105.06 0.2 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.703 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 26' ' ' GLN . 6.9 m -70.49 112.83 7.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.0 111.19 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 97' ' ' THR . 0.5 OUTLIER -94.43 116.36 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.96 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 71.7 p -84.25 135.79 34.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.789 0.328 . . . . 0.0 110.588 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -136.73 106.8 6.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.247 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 75' ' ' ILE . 8.9 tp -79.46 110.55 14.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.875 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.681 ' CG2' HD12 ' A' ' 25' ' ' ILE . 17.6 m -107.87 171.1 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.509 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 80.6 t80 -134.66 118.39 17.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.432 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.63 145.12 36.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.245 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.03 117.25 20.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.777 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.45 -172.46 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -166.84 1.55 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.087 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -85.73 155.45 21.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.6 t -97.94 7.26 8.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.128 0.489 . . . . 0.0 111.599 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.54 175.34 34.91 Favored Glycine 0 C--N 1.315 -0.594 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.56 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.811 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -166.67 141.25 4.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.72 0.295 . . . . 0.0 110.784 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 ptt-85 -98.02 144.93 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.811 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -128.97 156.02 44.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.049 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -112.35 129.18 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.372 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.9 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -131.34 122.84 51.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.047 0.451 . . . . 0.0 111.748 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.38 129.58 52.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.809 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.695 HD12 ' CD1' ' A' ' 105' ' ' LEU . 22.0 mt -122.0 126.96 49.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 112.058 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -78.3 111.95 14.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.428 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 120.82 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.026 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.04 -123.35 4.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.95 -49.44 2.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.87 0.367 . . . . 0.0 110.995 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -85.17 57.3 4.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.94 -130.57 51.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.337 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.7 HD13 ' CE2' ' A' ' 36' ' ' PHE . 3.0 mt -123.43 -19.45 5.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.597 0.237 . . . . 0.0 111.352 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 86.42 24.88 38.05 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.808 -0.71 . . . . 0.0 113.084 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CE2' HD13 ' A' ' 34' ' ' LEU . 21.3 p90 -143.22 127.91 18.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.956 0.408 . . . . 0.0 111.335 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.01 134.57 49.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.775 HD12 HG21 ' A' ' 51' ' ' ILE . 19.4 pt -113.06 140.47 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.366 0.603 . . . . 0.0 111.968 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -102.38 166.52 10.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.311 179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -114.16 125.77 54.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.39 65.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.053 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 59.4 52.52 5.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.0 p -87.42 -46.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -104.0 149.09 25.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.37 -30.24 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.384 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 39.47 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.96 -90.19 1.3 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.33 109.83 17.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.51 125.32 21.54 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.973 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.91 132.61 23.45 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.557 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.775 HG21 HD12 ' A' ' 38' ' ' ILE . 5.3 mm -99.24 137.66 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.3 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.22 173.24 9.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.753 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 56' ' ' ILE . 19.9 t -93.32 100.81 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.064 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 1.5 tppp? -59.8 -31.85 70.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.773 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.31 146.89 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.003 0.43 . . . . 0.0 111.756 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.795 HD11 HG11 ' A' ' 53' ' ' VAL . 34.0 mm -101.13 98.14 6.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.358 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.52 147.65 20.13 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.299 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.642 ' HA ' HD13 ' A' ' 63' ' ' ILE . 90.4 Cg_endo -83.54 12.62 2.92 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 113.489 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.68 83.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.819 0.342 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -174.22 -178.92 44.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.696 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.54 -25.7 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -67.04 -55.43 14.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 111.506 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -64.16 -36.29 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.48 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 1.6 pt20 -71.37 -35.13 70.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.867 0.365 . . . . 0.0 110.42 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD2' HD23 ' A' ' 27' ' ' LEU . 18.6 m-20 -71.34 -33.88 70.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.1 50.75 58.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.657 ' HB2' HG23 ' A' ' 25' ' ' ILE . 69.2 mtt180 -129.41 -47.47 1.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.706 0.289 . . . . 0.0 111.078 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.9 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.46 119.89 40.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.649 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.532 ' O ' HD12 ' A' ' 68' ' ' LEU . 54.2 mttt -107.5 -169.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.03 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -83.51 165.38 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.2 81.03 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.691 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -98.96 163.85 12.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.725 0.298 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -120.29 118.42 30.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.064 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.545 ' CD1' HG21 ' A' ' 38' ' ' ILE . 1.1 mp -68.52 110.85 4.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.112 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.665 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.4 mt -92.16 -28.37 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.156 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -158.75 149.95 20.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 0.0 111.699 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HD11 ' A' ' 82' ' ' LEU . 82.6 t -139.21 124.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.461 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 60.27 29.82 19.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.957 0.408 . . . . 0.0 110.798 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.94 15.3 81.77 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.804 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG11 ' HE3' ' A' ' 85' ' ' LYS . 79.7 t -108.21 149.04 11.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.326 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -83.73 117.48 23.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.351 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 77' ' ' VAL . 3.0 mt -86.93 18.44 3.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 75.39 2.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.869 0.366 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.94 -15.34 2.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.594 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HE3' HG11 ' A' ' 80' ' ' VAL . 13.9 mttm -73.04 -95.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.484 0.183 . . . . 0.0 110.925 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.792 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER 163.97 168.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.882 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.5 tt0 -68.7 -54.45 16.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -61.8 -30.5 70.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -69.7 -54.92 11.54 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.72 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 86' ' ' SER . 80.1 t -56.88 -45.72 83.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.589 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 87' ' ' GLN . 40.9 t -63.26 -32.15 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.968 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 t -65.01 -35.08 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.277 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.7 mt -66.96 -52.39 43.46 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.127 0.489 . . . . 0.0 110.301 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.551 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.9 pp -68.26 -33.36 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.683 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.7 mtt-85 -72.73 -31.01 64.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.1 t -61.64 -37.26 83.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.21 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.054 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -48.12 132.53 15.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.524 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -98.09 175.1 6.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.053 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.9 mmt -51.42 147.67 5.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.581 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 55.59 80.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.947 0.404 . . . . 0.0 110.088 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.02 108.4 0.24 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 115.3 8.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.069 0.462 . . . . 0.0 111.066 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.054 HG22 HG21 ' A' ' 97' ' ' THR . 1.2 t -94.15 121.04 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.123 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.3 p -84.36 130.0 34.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.765 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.695 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -134.53 111.27 9.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.245 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.665 HD23 ' HB ' ' A' ' 75' ' ' ILE . 15.1 tp -84.23 125.12 31.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.012 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 25' ' ' ILE . 10.1 m -116.91 168.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.898 0.38 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.8 t80 -135.8 121.43 19.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.723 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -109.06 141.08 41.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -89.92 139.32 30.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.91 145.94 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.31 94.67 3.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.75 0.31 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -104.56 31.94 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 20' ' ' GLY . 17.8 t -143.32 160.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 125.02 162.82 11.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.666 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -151.52 151.87 32.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.771 0.32 . . . . 0.0 110.634 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HD3' HD12 ' A' ' 75' ' ' ILE . 17.4 mtm180 -93.81 148.84 21.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.327 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -132.3 156.04 47.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -111.93 120.29 41.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.267 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.817 HG21 ' HB3' ' A' ' 68' ' ' LEU . 2.5 mp -135.71 113.78 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.928 0.394 . . . . 0.0 111.583 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -108.11 134.46 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.119 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 62' ' ' ALA . 23.3 mt -113.81 151.92 31.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.24 0.543 . . . . 0.0 112.026 -178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -93.86 113.22 25.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.382 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -51.82 127.18 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.334 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.57 -131.58 1.96 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.17 155.58 16.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.933 0.397 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.04 40.57 18.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 61.01 -124.21 34.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.601 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HE1' ' A' ' 36' ' ' PHE . 19.1 mt -113.47 -21.52 10.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 111.336 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.73 18.82 46.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.688 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.641 ' HZ ' HD13 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -139.1 131.29 28.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.033 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.18 134.48 49.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.764 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.744 HD12 HG21 ' A' ' 51' ' ' ILE . 25.1 pt -113.89 140.3 35.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 112.231 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 52' ' ' TYR . 0.6 OUTLIER -99.2 170.21 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.061 178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 p -131.09 129.28 41.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.843 0.354 . . . . 0.0 111.358 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' ' CE1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -62.89 -29.07 70.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.833 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.24 55.63 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 50' ' ' PRO . 54.8 t -77.0 -70.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -103.61 143.42 32.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.927 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.86 -32.84 33.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.394 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.31 32.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.61 -92.61 2.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.56 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 m -148.23 107.74 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.829 0.347 . . . . 0.0 111.095 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.51 138.47 25.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 43' ' ' VAL . 71.8 Cg_endo -77.81 137.38 15.9 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.372 2.048 . . . . 0.0 112.757 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 38' ' ' ILE . 2.7 mm -105.57 139.24 27.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 39' ' ' THR . 4.1 m-85 -126.11 174.09 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.609 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 72' ' ' ASP . 40.0 t -95.27 98.9 8.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.949 0.404 . . . . 0.0 110.805 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -60.17 -32.08 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.138 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -179.41 154.82 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.147 0.499 . . . . 0.0 111.906 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 53' ' ' VAL . 28.3 mm -106.29 98.48 6.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.406 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.44 150.34 17.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.6 Cg_endo -82.96 16.75 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.86 2.374 . . . . 0.0 113.75 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -147.91 88.43 1.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.843 0.354 . . . . 0.0 111.172 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.621 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -175.28 -179.95 46.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.429 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.28 -29.67 60.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -63.45 -54.85 30.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 111.41 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.0 tt -57.44 -31.68 39.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.639 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -68.67 -46.56 68.8 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.13 0.49 . . . . 0.0 110.101 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.36 -33.7 73.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.529 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.38 36.34 90.81 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.329 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.717 ' HB2' HG23 ' A' ' 25' ' ' ILE . 13.7 mtp180 -107.07 -37.31 6.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.697 0.284 . . . . 0.0 111.064 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.55 119.73 38.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 110.588 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 68' ' ' LEU . 10.5 mttm -112.05 -169.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.144 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.2 155.44 36.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.88 -12.5 65.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.765 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.34 143.06 50.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -103.71 117.61 34.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.088 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -70.97 116.3 11.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.448 HD12 ' HD3' ' A' ' 22' ' ' ARG . 3.4 mt -104.35 -27.83 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 41.6 mt-10 -157.66 154.14 27.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.403 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.997 HG23 HD11 ' A' ' 82' ' ' LEU . 92.9 t -139.28 128.87 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.901 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.563 HD22 HG13 ' A' ' 103' ' ' VAL . 0.5 OUTLIER 47.63 36.45 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.07 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.04 23.22 61.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.353 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.19 146.79 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.92 0.391 . . . . 0.0 111.17 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -91.6 79.87 5.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.435 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.997 HD11 HG23 ' A' ' 77' ' ' VAL . 36.7 mt -49.05 -26.48 2.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.181 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 91.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.39 25.98 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.699 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 86' ' ' SER . 5.4 mmtt -113.0 -92.48 0.48 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.894 -0.18 . . . . 0.0 111.014 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.776 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 164.94 165.5 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 110.304 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.856 ' O ' HG23 ' A' ' 91' ' ' VAL . 3.4 tp-100 -68.57 -54.44 16.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.05 0.453 . . . . 0.0 109.878 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.36 -30.44 71.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.484 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 50.5 mm-40 -70.95 -51.07 27.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.624 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.823 HG22 HD22 ' A' ' 82' ' ' LEU . 72.3 t -59.32 -45.59 93.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.287 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.5 t -62.09 -32.44 54.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.998 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.83 -37.19 86.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.338 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -63.1 -52.16 63.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.183 0.516 . . . . 0.0 110.046 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.641 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -67.46 -36.87 82.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.163 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.757 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -71.23 -30.8 66.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.659 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.3 t -63.77 -39.0 93.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.055 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -55.06 129.67 38.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.691 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -176.92 3.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.5 mmt -52.93 147.3 9.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 58.83 83.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.06 105.06 0.19 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.84 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 93.2 m -70.76 106.83 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.963 0.411 . . . . 0.0 110.822 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.055 HG22 HG21 ' A' ' 97' ' ' THR . 40.7 t -94.5 110.73 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.564 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -84.36 113.88 21.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.803 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.94 117.09 31.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.414 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.73 111.82 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.088 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.625 HG22 HD12 ' A' ' 25' ' ' ILE . 12.1 m -107.31 175.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.789 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 10.1 t80 -131.53 119.87 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.307 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.565 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -115.21 143.7 44.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 111.219 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -82.14 143.62 31.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.631 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -109.87 156.4 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.047 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 68.44 -68.67 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.87 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -59.98 -175.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 19' ' ' VAL . 21.6 t -108.76 6.63 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.232 0.539 . . . . 0.0 111.547 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.43 142.67 11.87 Favored Glycine 0 C--N 1.314 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.311 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 -178.12 5.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.767 0.318 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.568 ' HD2' HD21 ' A' ' 106' ' ' LEU . 15.3 ttp-105 -122.7 146.38 47.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.2 152.68 48.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.945 0.403 . . . . 0.0 111.149 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.32 113.16 25.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.905 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -112.76 116.45 52.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 111.787 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.94 122.95 45.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.838 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' HB2' HD23 ' A' ' 34' ' ' LEU . 97.2 mt -111.88 129.77 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.885 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -87.33 113.24 22.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.478 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.11 129.02 33.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 111.092 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 31' ' ' THR . . . -110.85 -72.13 0.67 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.505 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' GLY . 1.3 p -160.04 -52.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -90.5 59.45 4.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.81 -136.57 51.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.384 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD13 ' HE1' ' A' ' 36' ' ' PHE . 4.6 mp -122.87 -12.49 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.59 0.233 . . . . 0.0 111.386 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 80.03 37.33 22.39 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.841 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HE1' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -149.93 127.64 11.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.037 0.446 . . . . 0.0 111.426 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.4 t -112.31 134.61 53.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.728 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.845 HG21 ' CD1' ' A' ' 74' ' ' LEU . 2.7 pp -111.54 145.46 17.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.428 0.632 . . . . 0.0 112.125 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -103.57 169.42 8.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.38 179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.0 p -135.07 122.84 22.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.134 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.11 -30.98 69.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.638 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 59.68 69.26 0.72 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.037 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG23 ' HD2' ' A' ' 50' ' ' PRO . 31.8 t -73.64 -36.12 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -137.73 165.88 25.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -67.91 91.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.181 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.73 83.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.521 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.72 -115.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 44' ' ' THR . 0.4 OUTLIER -83.07 106.53 14.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.968 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.95 137.45 10.45 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.848 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 43' ' ' VAL . 87.2 Cg_endo -78.98 139.07 15.02 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.629 2.219 . . . . 0.0 113.271 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' CG2' HD13 ' A' ' 38' ' ' ILE . 1.3 mm -115.85 142.81 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.658 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ARG . 1.2 p90 -153.77 149.07 27.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.205 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 68' ' ' LEU . 42.3 t -52.86 118.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 53.3 tttm -84.89 -27.98 26.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.34 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -177.78 144.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.005 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.412 HD11 HG11 ' A' ' 53' ' ' VAL . 30.9 mm -99.66 126.03 53.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.13 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 14.0 mt -81.13 146.32 58.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HA ' HD13 ' A' ' 63' ' ' ILE . 5.7 Cg_exo -74.37 -2.34 12.24 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.959 2.439 . . . . 0.0 113.337 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -133.62 81.18 1.91 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 111.403 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -164.99 -179.52 39.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.7 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.57 -33.0 60.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . . . -61.84 -55.11 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.8 tt -59.68 -37.15 69.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 9.7 pt20 -71.2 -35.53 71.58 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.59 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.4 -33.9 69.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.712 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 41.23 99.19 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.276 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB2' HG23 ' A' ' 25' ' ' ILE . 19.2 mtp180 -115.87 -45.8 2.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.138 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.905 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -112.25 119.92 40.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.773 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' N ' HD12 ' A' ' 68' ' ' LEU . 29.7 mttm -117.11 -168.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.176 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.95 160.34 29.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.24 89.69 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.611 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 1.4 m-20 -100.7 138.56 37.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.637 0.256 . . . . 0.0 110.567 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -100.02 136.81 39.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.088 0.47 . . . . 0.0 111.331 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.845 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -80.96 117.4 21.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.97 -27.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.098 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . 13.9 mt-10 -160.03 149.67 18.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.554 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HD11 ' A' ' 82' ' ' LEU . 62.1 t -138.97 126.31 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.651 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.03 30.33 16.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.876 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.38 18.95 70.08 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.475 HG11 ' NZ ' ' A' ' 85' ' ' LYS . 98.6 t -108.21 149.15 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 111.201 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.19 115.12 25.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.496 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.029 HD11 HG23 ' A' ' 77' ' ' VAL . 5.6 mt -87.49 20.56 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.54 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 0.0 110.921 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.49 44.86 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.278 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.582 ' NZ ' HD11 ' A' ' 93' ' ' LEU . 11.0 mtmt -118.42 -91.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 122.94 -0.153 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.85 ' O ' HG23 ' A' ' 90' ' ' VAL . 1.9 t 164.64 159.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.857 ' O ' HG23 ' A' ' 91' ' ' VAL . 45.5 tt0 -69.13 -54.18 16.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -30.3 70.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.846 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 86' ' ' SER . 7.0 mm-40 -71.67 -51.65 21.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.635 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 86' ' ' SER . 96.4 t -58.59 -44.64 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.523 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.7 t -62.99 -32.75 57.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -64.65 -35.75 82.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.103 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.582 HD11 ' NZ ' ' A' ' 85' ' ' LYS . 6.2 mt -63.39 -51.92 63.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -65.9 -37.34 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.979 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -71.04 -30.83 67.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.781 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -45.22 95.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.032 HG21 HG22 ' A' ' 103' ' ' VAL . 0.7 OUTLIER -53.04 122.16 8.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.926 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.4 -172.19 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.93 134.65 7.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.027 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.3 89.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.904 0.383 . . . . 0.0 110.262 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.15 103.77 0.19 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.041 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.19 106.5 3.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 110.878 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.032 HG22 HG21 ' A' ' 97' ' ' THR . 2.8 t -94.48 115.47 33.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.8 p -84.67 122.45 29.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.649 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 77' ' ' VAL . 3.8 mt -122.08 109.3 14.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.316 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HD2' ' A' ' 22' ' ' ARG . 26.7 tp -79.73 111.83 16.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.537 HG22 HD12 ' A' ' 25' ' ' ILE . 3.5 m -117.33 164.7 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.516 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 20.2 t80 -130.53 123.61 30.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.238 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 145.21 26.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -134.0 152.05 51.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -129.45 178.67 6.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.128 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -104.61 -26.69 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.032 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.162 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.218 -179.916 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.73 0.3 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 177.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 20' ' ' GLY . 16.5 t -116.07 160.18 15.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 147.3 155.66 6.66 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.497 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -144.49 142.7 30.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.845 0.355 . . . . 0.0 110.803 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -95.86 143.98 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.692 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -139.12 141.98 38.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.335 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 106' ' ' LEU . 7.6 p30 -85.2 126.17 33.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.234 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 68' ' ' LEU . 44.9 mt -134.3 109.85 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 111.681 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.421 ' CB ' ' HA ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -106.7 155.11 20.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 179.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 34' ' ' LEU . 17.2 mt -140.65 130.16 24.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.962 0.41 . . . . 0.0 112.084 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 19.9 tptm -71.15 113.29 8.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.551 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 99' ' ' MET . 13.0 tptp -56.04 108.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.28 -96.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.413 ' HA ' ' CE ' ' A' ' 99' ' ' MET . 14.5 t -158.61 29.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.775 0.321 . . . . 0.0 110.983 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.06 41.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' HD12 ' A' ' 34' ' ' LEU . . . 81.29 -132.74 11.42 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.406 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 27' ' ' LEU . 6.1 mp -132.2 4.57 4.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.0 111.574 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 58.46 31.83 67.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.28 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -141.49 127.63 19.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.253 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -107.28 134.71 49.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.892 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.844 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.7 pp -115.72 147.11 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.229 0.538 . . . . 0.0 111.968 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -106.11 171.02 7.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.413 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 p -127.46 128.41 45.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.441 ' HD3' HG22 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -55.25 -24.88 30.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 62.57 56.5 2.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.901 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG22 ' HD3' ' A' ' 41' ' ' ARG . 22.1 t -75.95 -48.95 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.98 160.52 39.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.3 81.82 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.417 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.21 -23.32 32.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.791 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.04 -143.5 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.502 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 136.52 33.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.16 126.0 1.92 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.699 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.17 133.69 27.3 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.436 2.091 . . . . 0.0 112.736 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.786 HG13 HG21 ' A' ' 90' ' ' VAL . 3.5 mm -101.45 139.39 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.981 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 5.1 m-85 -130.23 174.23 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.075 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 56' ' ' ILE . 34.4 t -92.47 103.32 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 9.7 tttt -75.19 -29.55 60.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.19 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.68 154.94 12.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.145 0.498 . . . . 0.0 112.102 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.578 HD11 HG11 ' A' ' 53' ' ' VAL . 12.4 mm -120.77 98.82 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.134 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.3 mt -58.89 148.22 70.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.572 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.805 ' HA ' HD13 ' A' ' 63' ' ' ILE . 91.5 Cg_endo -81.29 8.23 4.5 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.926 2.417 . . . . 0.0 113.487 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.17 80.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.829 0.347 . . . . 0.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -169.69 -179.93 41.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.748 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -76.15 -23.39 54.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -71.45 -55.25 8.26 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.466 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.805 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.1 tt -64.38 -33.34 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.456 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 7.0 pt20 -71.56 -36.95 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.31 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.43 -37.45 71.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.38 64.44 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.4 -45.41 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 111.253 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB3' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -109.25 126.59 53.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.724 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.32 -169.45 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.966 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.33 168.96 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.208 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.18 21.86 77.23 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.9 143.43 45.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 111.091 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -110.3 117.85 34.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.715 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -67.88 114.5 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.323 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.666 ' HB ' HD23 ' A' ' 106' ' ' LEU . 4.2 mt -89.55 -28.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.902 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -169.31 173.15 6.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.995 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.855 HG23 HD11 ' A' ' 82' ' ' LEU . 98.4 t -148.92 126.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.5 m120 55.08 30.32 14.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 110.703 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.43 11.87 74.13 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.723 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG11 ' CE ' ' A' ' 85' ' ' LYS . 89.0 t -108.35 120.47 59.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.894 0.378 . . . . 0.0 111.46 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 76' ' ' GLU . 0.3 OUTLIER -70.67 117.03 11.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.068 178.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.855 HD11 HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -82.76 18.37 1.59 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.263 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.6 79.01 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.784 0.326 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.33 -8.06 4.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.77 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' CE ' HG11 ' A' ' 80' ' ' VAL . 10.8 mttt -76.41 -99.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.676 0.238 . . . . 0.0 111.027 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 167.15 173.84 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.76 0.315 . . . . 0.0 110.543 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 51.3 tt0 -68.39 -54.22 18.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 109.955 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.48 -30.14 71.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.57 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -73.13 -42.87 62.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.355 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.827 HG22 HD22 ' A' ' 82' ' ' LEU . 53.5 t -69.49 -42.43 80.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.553 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 37.7 t -68.94 -32.08 53.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.927 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 32.3 t -68.63 -48.05 65.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.775 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.659 HD21 ' HA ' ' A' ' 90' ' ' VAL . 1.1 pp -61.31 -39.04 89.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 94' ' ' LEU . 1.2 pp -78.28 -28.84 47.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.274 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -72.66 -30.15 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.662 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -59.49 -35.77 74.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.184 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.968 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.01 132.58 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.689 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.44 165.4 11.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.432 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -46.99 155.2 0.29 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 55.88 72.27 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.09 0.471 . . . . 0.0 110.067 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.56 108.34 0.24 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 3.0 m -70.45 121.0 16.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.24 0.543 . . . . 0.0 111.44 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.968 ' CG2' HG21 ' A' ' 97' ' ' THR . 21.0 t -94.16 111.03 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' CB ' ' A' ' 26' ' ' GLN . 78.7 p -84.15 113.48 21.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.9 112.07 17.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.666 HD23 ' HB ' ' A' ' 75' ' ' ILE . 5.3 tp -81.37 114.99 20.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.865 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.421 ' CG2' HD12 ' A' ' 23' ' ' LEU . 8.1 m -105.12 168.83 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.105 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' HB2' HD11 ' A' ' 75' ' ' ILE . 38.1 t80 -127.26 120.32 28.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.461 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -101.83 131.13 48.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.967 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 122.45 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.0 165.84 15.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.09 -172.66 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.86 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -110.21 131.75 54.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.3 t -96.42 159.35 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 59.68 158.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.554 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -145.14 138.44 26.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.51 147.26 24.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 -179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.652 HD21 ' CD ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -132.09 154.14 49.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.137 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -113.44 118.29 34.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.12 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.91 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.9 mp -121.92 131.29 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.483 . . . . 0.0 111.777 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.29 118.74 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.921 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' A' ' 62' ' ' ALA . 17.9 mt -111.75 135.01 52.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.652 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 tptm -87.6 121.25 29.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.896 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 121.22 8.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.73 -86.51 1.93 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.543 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.25 -55.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.787 0.327 . . . . 0.0 110.735 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.72 58.05 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.613 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.33 40.88 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.045 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 27' ' ' LEU . 4.0 mp -115.0 -21.77 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.662 0.268 . . . . 0.0 111.156 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.06 21.04 26.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.315 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HE1' HD22 ' A' ' 34' ' ' LEU . 27.2 p90 -138.18 128.79 26.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.915 0.388 . . . . 0.0 111.62 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.44 134.62 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.939 HD12 HG21 ' A' ' 51' ' ' ILE . 22.2 pt -116.07 141.24 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.352 0.596 . . . . 0.0 112.406 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 54' ' ' LYS . 1.4 t -102.01 171.21 7.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.876 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 2.6 t -126.76 124.9 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.843 0.354 . . . . 0.0 111.222 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -32.43 72.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.36 61.88 1.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.69 HG23 ' HD2' ' A' ' 50' ' ' PRO . 42.8 t -62.75 -51.7 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.905 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.82 162.51 36.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.66 -26.25 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.298 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.0 -26.51 8.77 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.726 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.52 -26.6 7.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.53 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 104.89 2.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.53 137.64 8.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.732 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 43' ' ' VAL . 65.7 Cg_endo -74.1 138.93 26.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.642 2.228 . . . . 0.0 113.094 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.939 HG21 HD12 ' A' ' 38' ' ' ILE . 4.0 mm -103.26 144.82 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.99 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 73' ' ' ARG . 3.8 m-85 -136.62 165.27 26.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.626 HG11 HD11 ' A' ' 56' ' ' ILE . 18.7 t -90.1 100.3 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.469 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CG2' ' A' ' 39' ' ' THR . 0.8 OUTLIER -73.08 -28.87 62.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.8 -179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.25 156.18 26.06 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.626 HD11 HG11 ' A' ' 53' ' ' VAL . 31.4 mm -119.72 96.17 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.623 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . 17.2 mt -52.76 148.08 14.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.51 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.564 ' HA ' HD13 ' A' ' 63' ' ' ILE . 98.0 Cg_endo -79.6 7.17 4.67 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.82 2.346 . . . . 0.0 113.42 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.52 82.07 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.796 0.331 . . . . 0.0 111.027 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -171.26 166.7 39.82 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.515 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.2 -38.84 80.87 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.706 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -55.85 -55.43 32.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.5 tt -61.1 -32.16 51.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.661 0.267 . . . . 0.0 111.513 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.43 ' CG ' ' O ' ' A' ' 60' ' ' GLY . 1.3 mm100 -71.08 -43.9 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 0.0 110.19 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.37 -33.78 69.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.644 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.3 52.84 49.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.231 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.604 ' HB2' HG23 ' A' ' 25' ' ' ILE . 18.1 mtt180 -123.88 -43.04 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.714 0.293 . . . . 0.0 111.119 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.91 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -111.05 120.78 43.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.66 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' O ' HD12 ' A' ' 68' ' ' LEU . 31.4 mttt -108.72 -170.62 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.69 165.18 22.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.012 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.11 14.06 83.0 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.657 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.648 ' OD2' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -92.55 156.32 17.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.829 0.347 . . . . 0.0 110.774 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 52.7 ttp180 -112.52 107.96 16.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.766 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -60.81 120.11 9.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.032 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 76' ' ' GLU . 3.4 mt -108.57 -27.4 2.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.751 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 75' ' ' ILE . 53.0 mt-10 -156.8 159.74 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.468 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.807 HG23 HD11 ' A' ' 82' ' ' LEU . 43.6 t -146.16 115.61 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 58.54 32.15 21.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.84 11.64 76.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.822 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.2 t -108.13 149.18 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.99 118.94 32.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.361 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.849 HD22 HG22 ' A' ' 90' ' ' VAL . 11.5 mt -82.77 13.96 3.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.578 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.33 64.32 8.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.176 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 151.9 -22.02 0.9 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.773 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.569 0.185 . . . . 0.0 110.966 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.8 t 166.19 172.92 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.788 0.328 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.874 ' O ' HG23 ' A' ' 91' ' ' VAL . 4.7 tp-100 -68.61 -54.61 15.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -30.34 71.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.574 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 35.7 mt-10 -70.52 -54.1 13.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.5 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.849 HG22 HD22 ' A' ' 82' ' ' LEU . 74.8 t -56.85 -45.33 83.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.565 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 87' ' ' GLN . 42.2 t -64.75 -32.53 58.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.247 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.38 -35.86 82.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.64 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.2 mt -68.31 -52.38 34.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.937 0.398 . . . . 0.0 110.361 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 94' ' ' LEU . 2.3 pp -67.33 -31.43 71.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.567 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.82 ' HG3' HG12 ' A' ' 91' ' ' VAL . 5.2 mtt180 -72.52 -30.79 64.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.625 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.7 t -60.02 -39.37 85.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.951 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -49.99 131.61 22.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.731 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.58 -171.51 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.852 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -53.27 141.67 23.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.614 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 59.11 81.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.359 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -176.42 104.19 0.19 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.871 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -71.0 112.9 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 0.0 111.019 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.951 ' CG2' HG21 ' A' ' 97' ' ' THR . 4.1 t -94.26 118.79 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.405 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.34 132.39 34.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.715 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.559 HD23 HG13 ' A' ' 77' ' ' VAL . 1.9 mt -135.97 108.88 7.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.182 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.8 tp -85.13 110.63 19.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.876 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.648 HG21 ' OD2' ' A' ' 72' ' ' ASP . 6.0 m -106.14 165.04 4.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.135 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 9.1 t80 -134.71 125.67 27.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 110.68 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -103.16 135.3 45.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.047 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.96 117.72 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.57 157.7 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.43 121.24 11.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 mttm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.788 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.11 40.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 20' ' ' GLY . 14.6 t -133.02 160.09 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 100.15 142.78 13.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' NZ ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -143.06 -171.74 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.821 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 7.9 ptt-85 -121.22 140.16 52.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.041 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -136.41 148.71 47.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.32 -179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.92 125.0 44.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.244 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 5.6 mt -126.39 113.12 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.916 0.389 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 4.3 mp0 -88.39 122.04 31.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.104 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 62' ' ' ALA . 19.5 mt -111.79 130.53 55.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.041 0.448 . . . . 0.0 111.877 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -82.23 111.54 18.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.526 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.59 140.15 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.32 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.66 -157.97 8.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.415 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.7 p -91.54 -32.33 15.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.48 53.26 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.023 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.73 -140.3 44.11 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD13 ' CE2' ' A' ' 36' ' ' PHE . 4.8 mt -115.12 -25.3 8.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.704 0.287 . . . . 0.0 111.023 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 95.79 24.72 14.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.643 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' CE2' HD13 ' A' ' 34' ' ' LEU . 23.1 p90 -150.6 132.31 14.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.863 0.364 . . . . 0.0 111.293 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.1 m -106.77 134.58 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.912 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' CD1' ' A' ' 74' ' ' LEU . 24.2 pt -104.26 139.43 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.359 0.599 . . . . 0.0 112.129 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -109.83 167.14 10.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.353 178.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 t -117.49 128.14 54.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.38 -28.17 66.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 62.35 49.75 4.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 44' ' ' THR . 3.3 p -70.53 -46.55 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.187 0.518 . . . . 0.0 111.053 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.461 ' N ' ' CG1' ' A' ' 43' ' ' VAL . 0.6 OUTLIER -109.03 159.1 17.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.844 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.41 -30.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.349 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.18 95.12 0.1 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.14 -38.32 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.49 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.44 105.73 1.12 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.07 139.59 23.87 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.441 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 15.1 Cg_exo -68.29 125.94 13.62 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 112.368 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG21 ' A' ' 90' ' ' VAL . 4.3 mm -93.93 136.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.86 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CE2' ' CG ' ' A' ' 73' ' ' ARG . 85.5 m-85 -126.96 174.23 9.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 56' ' ' ILE . 39.7 t -93.55 98.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.932 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.7 OUTLIER -51.59 -32.25 27.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.14 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 p30 176.09 158.14 0.26 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.081 0.467 . . . . 0.0 112.057 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD11 HG11 ' A' ' 53' ' ' VAL . 29.1 mm -108.21 96.87 5.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.255 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.12 153.79 6.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.287 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HA ' HD13 ' A' ' 63' ' ' ILE . 87.5 Cg_endo -83.07 21.67 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.85 2.367 . . . . 0.0 113.606 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.5 89.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 111.33 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -176.74 179.67 47.6 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.731 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.61 -26.89 58.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.79 ' HA ' HD21 ' A' ' 27' ' ' LEU . . . -66.5 -53.68 32.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.272 . . . . 0.0 111.379 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 58' ' ' PRO . 3.3 tt -60.79 -39.29 81.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.753 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 20.8 pt20 -71.34 -34.86 70.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.722 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -71.19 -33.78 70.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.706 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.34 51.56 55.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.317 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' HG23 ' A' ' 25' ' ' ILE . 80.7 mtt180 -128.11 -50.29 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.857 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.58 119.71 40.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.555 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.2 mmtt -106.1 -172.25 2.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.202 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.36 152.56 32.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.975 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.67 45.55 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.433 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -61.36 141.62 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.788 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -98.9 122.0 41.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.777 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HG21 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -73.62 110.09 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.763 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.586 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.9 mt -93.9 -28.84 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -159.01 162.95 36.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.968 0.413 . . . . 0.0 111.566 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 HD11 ' A' ' 82' ' ' LEU . 57.5 t -146.12 117.89 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.721 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' OD1' HG13 ' A' ' 103' ' ' VAL . 3.3 m120 58.44 31.01 20.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.93 18.29 63.58 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.728 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.4 ' CG1' ' HE2' ' A' ' 85' ' ' LYS . 84.6 t -108.41 149.35 11.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.977 0.418 . . . . 0.0 111.219 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.98 115.0 27.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.369 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.779 HD11 HG23 ' A' ' 77' ' ' VAL . 1.4 mt -87.04 18.56 3.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.272 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.11 88.01 5.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.6 10.12 8.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.722 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 86' ' ' SER . 23.4 mttm -91.68 -93.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.633 0.216 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.5 OUTLIER 165.47 165.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 110.542 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.849 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -68.74 -54.3 16.85 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -63.47 -30.38 71.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.68 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 26.3 mt-10 -70.65 -50.48 36.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.558 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 86' ' ' SER . 74.6 t -61.14 -48.1 90.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.288 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 87' ' ' GLN . 46.6 t -60.14 -32.44 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.852 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.51 -37.22 86.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.166 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 6.3 mt -60.04 -51.67 68.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 109.715 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.16 -44.04 89.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.66 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -61.11 -30.93 70.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.4 t -64.02 -40.66 96.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.027 HG21 ' CG2' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -57.71 131.59 50.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.474 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.3 -177.19 3.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.041 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 147.11 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 59.31 83.06 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.401 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.45 104.89 0.19 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.802 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 26' ' ' GLN . 11.4 m -70.68 108.56 4.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.964 0.411 . . . . 0.0 110.928 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.027 ' CG2' HG21 ' A' ' 97' ' ' THR . 39.6 t -94.6 117.27 37.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.676 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.0 p -84.6 102.79 13.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.54 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.672 ' CD1' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -105.34 111.26 23.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.171 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD23 ' HB ' ' A' ' 75' ' ' ILE . 6.2 tp -81.15 110.44 16.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.091 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 25' ' ' ILE . 9.9 m -108.23 174.31 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.508 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 16.6 t80 -127.99 113.29 15.64 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.298 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.814 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.5 tpt180 -87.62 125.1 34.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.58 155.41 16.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HA ' HG11 ' A' ' 19' ' ' VAL . 17.1 tt0 60.25 109.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.51 30.99 3.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.885 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.977 0.418 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.22 95.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.935 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 20' ' ' GLY . 16.1 t -139.89 160.12 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.122 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . . . 147.79 -140.45 8.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.534 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.707 ' CD ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -160.87 145.18 13.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 0.0 110.82 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HG2' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -84.96 151.23 24.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.707 HD21 ' CD ' ' A' ' 21' ' ' LYS . 1.3 mt -133.07 156.12 47.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.063 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -113.72 128.81 56.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.901 HD13 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mp -129.12 120.59 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 111.522 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -103.08 118.51 36.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.217 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 62' ' ' ALA . 10.5 mt -113.48 135.18 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.048 0.451 . . . . 0.0 111.684 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tptp -82.76 117.0 22.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.62 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 97' ' ' THR . 0.0 OUTLIER -51.84 132.85 32.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.256 -179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.0 -154.75 8.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.542 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.42 -40.09 11.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.956 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -91.07 50.28 1.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.74 -137.08 49.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.666 HD12 ' HE1' ' A' ' 36' ' ' PHE . 47.8 mt -113.16 -22.38 10.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 60' ' ' GLY . . . 90.35 18.93 47.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.804 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HE1' HD12 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -140.11 132.22 27.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.956 0.408 . . . . 0.0 111.013 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 m -106.51 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 91' ' ' VAL . 23.3 pt -107.96 139.47 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.275 0.559 . . . . 0.0 112.156 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.45 HG22 ' CA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -109.73 164.53 12.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.277 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -125.05 130.43 52.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.997 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -24.89 64.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.846 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.33 54.44 2.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 ' CG2' ' HD2' ' A' ' 50' ' ' PRO . 41.3 t -67.74 -38.93 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 48' ' ' SER . 1.1 t -139.54 170.2 16.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.69 -66.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.36 56.0 0.6 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.487 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.85 -108.16 1.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 44' ' ' THR . 27.9 t -105.6 143.09 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.923 0.392 . . . . 0.0 111.01 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.99 124.55 0.45 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.808 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 41.1 Cg_endo -67.83 144.37 64.81 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.457 2.105 . . . . 0.0 112.724 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' CG2' ' HB ' ' A' ' 38' ' ' ILE . 1.4 mm -112.33 127.23 69.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.031 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 73' ' ' ARG . 6.7 m-85 -121.89 150.14 42.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.934 HG11 HD11 ' A' ' 56' ' ' ILE . 20.6 t -62.24 101.53 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 111.049 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.45 ' CA ' HG22 ' A' ' 39' ' ' THR . 8.9 ttmm -60.77 -31.44 70.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -175.39 157.7 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.828 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.934 HD11 HG11 ' A' ' 53' ' ' VAL . 27.8 mm -121.04 97.93 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.449 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 24.2 mt -60.88 149.03 82.13 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.25 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' HA ' HD13 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -85.78 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.009 2.473 . . . . 0.0 113.246 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -150.22 73.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 35' ' ' GLY . . . -163.35 -178.06 36.76 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.724 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . . . -75.82 -25.45 56.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' A' ' 27' ' ' LEU . . . -69.25 -55.22 11.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.408 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.713 HD13 ' HA ' ' A' ' 58' ' ' PRO . 2.2 tt -64.4 -35.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 61' ' ' ALA . 6.8 pt20 -71.34 -35.33 71.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.95 0.405 . . . . 0.0 110.286 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.39 -33.73 69.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.598 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.09 62.85 4.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.278 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.668 ' HB2' HG23 ' A' ' 25' ' ' ILE . 3.1 mtt180 -142.75 -48.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.28 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HB2' HD13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -106.66 121.22 43.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.797 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.513 ' O ' HD12 ' A' ' 68' ' ' LEU . 12.9 mttp -109.4 -169.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 56' ' ' ILE . . . -84.52 155.98 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.43 -12.19 67.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.664 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.429 ' HB3' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m-20 -75.39 160.45 30.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 110.973 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 52' ' ' TYR . 0.0 OUTLIER -117.34 119.5 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.061 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 82' ' ' LEU . 1.4 mp -70.21 113.55 7.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.034 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.581 ' HB ' HD23 ' A' ' 106' ' ' LEU . 3.8 mt -94.1 -28.15 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.031 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' HG22 ' A' ' 75' ' ' ILE . 69.6 mt-10 -157.69 164.36 37.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.761 HG23 HD11 ' A' ' 82' ' ' LEU . 61.5 t -148.64 122.1 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.19 30.7 18.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.02 70.62 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.749 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.22 149.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.965 0.412 . . . . 0.0 111.256 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.41 117.61 29.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.386 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.761 HD11 HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -87.13 17.32 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.202 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.24 90.82 6.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.904 0.383 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.2 5.29 19.74 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.569 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -86.37 -95.02 0.08 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.686 0.243 . . . . 0.0 110.846 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.79 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.4 OUTLIER 166.13 165.54 0.03 OUTLIER 'General case' 0 N--CA 1.46 0.056 0 CA-C-O 120.726 0.298 . . . . 0.0 110.485 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.834 ' O ' HG23 ' A' ' 91' ' ' VAL . 1.1 tp60 -68.86 -54.21 16.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.5 -30.5 71.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.629 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 6.9 mm-40 -71.03 -52.81 17.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.584 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 86' ' ' SER . 75.1 t -58.31 -44.61 88.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.369 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 87' ' ' GLN . 55.7 t -63.02 -32.38 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.838 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -33.82 76.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.15 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 89' ' ' GLU . 5.9 mt -64.74 -51.7 60.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.174 0.511 . . . . 0.0 109.956 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.81 -42.97 89.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.899 179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -66.57 -30.91 71.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -62.51 -39.53 93.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.991 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.016 HG21 HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -56.35 131.93 49.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.499 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -103.65 -173.51 2.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.212 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.3 mmt -56.12 149.22 16.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.765 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 55.9 78.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -174.2 103.3 0.18 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.085 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.8 m -71.09 112.18 7.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.911 0.386 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.016 HG22 HG21 ' A' ' 97' ' ' THR . 10.9 t -94.62 113.26 28.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.031 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.1 m -84.83 103.99 14.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.498 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 27' ' ' LEU . 1.3 mp -103.91 118.16 36.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.581 HD23 ' HB ' ' A' ' 75' ' ' ILE . 22.2 tp -80.6 127.24 32.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.036 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 72' ' ' ASP . 4.1 m -122.31 173.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 73' ' ' ARG . 23.6 t80 -134.32 128.99 34.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -116.85 115.8 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.55 138.92 35.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.37 146.05 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -67.69 -26.19 66.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.148 -179.917 . . . . . . . . 0 0 . 1 stop_ save_